Life's essential 8: updating and enhancing the American Heart Association's construct of cardiovascular health: a presidential advisory from the American Heart Association
Open accessAbstract
In 2010, the American Heart Association defined a novel construct of cardiovascular health to promote a paradigm shift from a focus solely on disease treatment to one inclusive of positive health promotion and preservation across the life course in populations and individuals. Extensive subsequent evidence has provided insights into strengths and limitations of the original approach to defining and quantifying cardiovascular health. In response, the American Heart Association convened a writing group to recommend enhancements and updates. The definition and quantification of each of the original metrics (Life’s Simple 7) were evaluated for responsiveness to interindividual variation and intraindividual change. New metrics were considered, and the age spectrum was expanded to include the entire life course. The foundational contexts of social determinants of health and psychological health were addressed as crucial factors in optimizing and preserving cardiovascular health. This presidential advisory introduces an enhanced approach to assessing cardiovascular health: Life’s Essential 8. The components of Life’s Essential 8 include diet (updated), physical activity, nicotine exposure (updated), sleep health (new), body mass index, blood lipids (updated), blood glucose (updated), and blood pressure. Each metric has a new scoring algorithm ranging from 0 to 100 points, allowing generation of a new composite cardiovascular health score (the unweighted average of all components) that also varies from 0 to 100 points. Methods for implementing cardiovascular health assessment and longitudinal monitoring are discussed, as are potential data sources and tools to promote widespread adoption in policy, public health, clinical, institutional, and community settings.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Preventing the development of hypertension reduces risk more than treating existing hypertension.
“Preventing the development of hypertension reduces risk more than treating existing hypertension.36,37”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [36]
In the Clinical Statements and Guidelines section (p. e28), the advisory recommends a lower cardiovascular-health score for treated blood pressure because people requiring treatment retain residual risk. This supports the idea that avoiding hypertension is preferable to relying on treatment, but it does not directly compare how much risk prevention reduces versus treatment. (LLM, conf=0.82)
Experimental — accuracy not yet measuredRegular assessments of lipids, glycemia, and kidney function are recommended with increasing frequency for higher CKM stages, as the risk for progressive metabolic and kidney disease increases along the CKM spectrum.
“Regular assessments of lipids, glycemia, and kidney function (eg, eGFR) are recommended with increasing frequency for higher CKM stages, as the risk for progressive metabolic and kidney disease increases along the CKM spectrum.13,18–21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
The Clinical Statements and Guidelines table describes measuring blood lipids and blood glucose as cardiovascular-health metrics. It does not recommend kidney-function assessment or specify increasingly frequent assessments at higher CKM stages, so the stage-based recommendation is not supported by this paper. (LLM, conf=0.82)
Experimental — accuracy not yet measuredUltimately, adverse SDOH have downstream consequences on cardiovascular and all-cause mortality and contribute to disparities in CVD mortality.
“Ultimately, adverse SDOH have downstream consequences on cardiovascular and all-cause mortality11,14 and contribute to disparities in CVD mortality.21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
The “SDOH and Considerations for Equitably Improving CVH Across Contexts” section says social determinants affect cardiovascular health and that structural barriers sustain disparities in cardiovascular health. Citation 21 is attached specifically to disparities in CVD mortality, which the cited passages do not establish; the cardiovascular and all-cause mortality clause has separate citations. (LLM, conf=0.85)
Experimental — accuracy not yet measuredThe unweighted average of the four CVD risk factors is common for composite CVD risk score generation.
“Because the exact relative importance of each CVD risk factor was unclear in this specific population, we used the unweighted average of the four CVD risk factors, which is also common for a composite CVD risk score generation.14”
From Aerobic, resistance, or combined exercise training and cardiovascular risk profile in overweight or obese adults: the CardioRACE trial (2024) · cites this paper as [14]
The Clinical Statements and Guidelines section endorses an unweighted average for a composite cardiovascular health score. But it averages all eight component metrics, not just the four CVD risk factors, and does not establish that this method is common for composite CVD risk scores. (LLM, conf=0.86)
Experimental — accuracy not yet measuredThe four traditional CVD risk factors (systolic blood pressure, LDL cholesterol, fasting glucose, and per cent body fat) are often included in routine composite CVD risk algorithms to predict future CVD in clinical practice.
“These four traditional CVD risk factors are often included in routine composite CVD risk algorithms to predict future CVD in clinical practice.10,11,14,22”
From Aerobic, resistance, or combined exercise training and cardiovascular risk profile in overweight or obese adults: the CardioRACE trial (2024) · cites this paper as [14]
The clinical scoring table (p. e26 and following) includes blood pressure and fasting glucose, and the implementation section says CVH metrics in electronic health records can support risk prediction. But the advisory uses BMI rather than percent body fat and non-HDL rather than LDL cholesterol for its composite CVH score. It does not establish that the four specified measures are often included together in routine clinical CVD risk algorithms. (LLM, conf=0.82)
Experimental — accuracy not yet measured
In a small randomized crossover trial of 44 adults with diabetes and food insecurity, a medically tailored meal delivery program improved dietary quality and food insecurity and reduced hypoglycemia.
“One small, randomized crossover trial among 44 adults with diabetes and food insecurity found that a medically tailored meal delivery program improved dietary quality and food insecurity and reduced hypoglycemia.21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
The Neighborhoods and Communities section discusses corner-store interventions addressing food insecurity, while the dietary-quality sections describe assessment methods. Searches for the 44-person crossover trial, medically tailored meal delivery, and hypoglycemia found no passage in our copy reporting the claimed results. (LLM, conf=0.75)
Experimental — accuracy not yet measuredMBS is the most potent weight loss therapy and has become safer with less invasive surgical options over time.
“MBS, the most potent weight loss therapy, has become safer, with less invasive surgical options over time.20,21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
The advisory’s Clinical Statements and Guidelines section discusses BMI scoring, but the passages found do not address metabolic and bariatric surgery as a weight-loss therapy. Searches for MBS, bariatric surgery, surgical weight loss, and changes in surgical safety or invasiveness found no passage supporting the claim. (LLM, conf=0.76)
Experimental — accuracy not yet measuredGreater amounts of intentional weight loss are associated with more substantial improvement in CKM risk factors, and ≥10% weight loss may reduce CVD risk.
“Greater amounts of intentional weight loss are associated with more substantial improvement in CKM risk factors,20 with some possible reductions in CVD risk with ≥10% weight loss.21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
The Outcomes of CVH section associates better overall cardiovascular health with lower CVD risk, and the Clinical Statements and Guidelines section scores BMI. Neither passage addresses whether greater intentional weight loss produces greater improvement in CKM risk factors or whether ≥10% weight loss may reduce CVD risk. Searches for intentional weight loss and the 10% threshold found no passage establishing those claims. (LLM, conf=0.73)
Experimental — accuracy not yet measuredTime-restricted eating has demonstrated some weight loss efficacy, but is no more effective than a calorie-limited approach in promoting weight loss or improving cardiovascular risk.
“Time-restricted eating, the most popular form of which is intermittent fasting, has demonstrated some weight loss efficacy,33,34 but studies indicate it is no more effective than a calorie-limited approach in promoting weight loss or improving cardiovascular risk.35,36”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [36]
The Diet section discusses overall eating patterns, not the effectiveness of time-restricted eating. A reference lists a study of nightly fasting and cardiometabolic risk, but our copy does not report weight-loss results or compare time-restricted eating with calorie restriction. Searches for intermittent fasting, calorie restriction, and cardiovascular risk found no passage addressing that comparison. (LLM, conf=0.76)
Experimental — accuracy not yet measuredCKM risk factor remission is superior with RYGB bypass compared with LSG.
“CKM risk factor remission is superior with RYGB bypass compared with LSG.20,21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
The Outcomes of CVH and Clinical Statements and Guidelines passages discuss cardiovascular health metrics and risk-factor scoring, not remission after bariatric surgery. Searches for RYGB versus LSG and for Roux-en-Y gastric bypass versus sleeve gastrectomy found no comparison in our copy. (LLM, conf=0.78)
Experimental — accuracy not yet measuredCounseling on dietary or combined dietary and exercise modifications effectively facilitates weight loss in postpartum women with GDM.
“Counseling on dietary or combined dietary and exercise modifications effectively facilitates weight loss in postpartum women with GDM.6,19–21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
The Life Course and Intergenerational Perspectives section identifies the postpartum period as an opportunity to improve cardiovascular health, but does not report weight-loss outcomes. Searches for gestational diabetes and dietary or exercise counseling found no passage establishing that these interventions facilitate weight loss in postpartum women with GDM. (LLM, conf=0.77)
Experimental — accuracy not yet measuredPopulation-based analyses demonstrate that the overwhelming majority of individuals with CKD and T2D or albuminuria have a 10-year PREVENT-CVD score ≥7.5%.
“population-based analyses demonstrating that the overwhelming majority of individuals with CKD and T2D or albuminuria have a 10-year PREVENT-CVD score ≥7.5%.21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
The Clinical Statements and Guidelines passage (p. e28) describes Life’s Essential 8 blood-glucose scoring, and the Outcomes of CVH passage discusses cardiovascular risk generally. Searches for PREVENT-CVD, CKD, albuminuria, and the ≥7.5% threshold found no passage reporting the claimed population-based analysis. (LLM, conf=0.76)
Experimental — accuracy not yet measuredClinical trials have indicated a lack of heterogeneity in the effects of each class of these cardioprotective glucose-lowering therapies between those who were and were not taking the other agent.
“Clinical trials have indicated a lack of heterogeneity in the effects of each class of these cardioprotective glucose-lowering therapies between those who were and were not taking the other agent.17–19,21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
The Clinical Statements and Guidelines passage (p. e28) discusses blood-glucose scoring and metformin use, not comparative effects of cardioprotective glucose-lowering therapies. Searches for heterogeneity and for concomitant SGLT2-inhibitor and GLP-1-receptor-agonist use found no passage in our copy addressing whether effects differed by use of the other agent. (LLM, conf=0.74)
Experimental — accuracy not yet measuredIncidentally identified moderate-to-severe coronary calcifications on a nongated chest computed tomography scan typically correlates with CAC ≥100, carries similar prognostic value, and can also identify patients with CKM syndrome most likely to benefit from preventive therapies.
“Incidentally identified moderate-to-severe coronary calcifications on a nongated chest computed tomography scan typically correlates with CAC ≥100, carries similar prognostic value, and can also identify patients with CKM syndrome most likely to benefit from preventive therapies.21–24”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredA more recent meta-analysis that included 10 GLP-1 RA trials estimated a 13% reduction in HF hospitalization (HR, 0.87 [95% CI, 0.80-0.94]).
“However, a more recent meta-analysis that included 10 GLP-1 RA trials estimated a 13% reduction in HF hospitalization (HR, 0.87 [95% CI, 0.80–0.94]).36”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [36]
The Clinical Statements and Guidelines section discusses blood-glucose scoring and diabetes, but does not report a GLP-1 receptor agonist meta-analysis or a heart-failure hospitalization estimate. Searches for GLP-1, 10 trials, and the stated hazard ratio and confidence interval found no passage addressing the claim. (LLM, conf=0.77)
Experimental — accuracy not yet measuredCardiovascular risk reduction with semaglutide was observed prior to clinically significant weight loss, and similar cardiovascular event reductions were observed regardless of the magnitude of weight achieved.
“CVD risk reduction was observed with semaglutide prior to clinically significant weight loss, and similar CVD event reductions were observed regardless of the magnitude of weight achieved,21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
The Outcomes of CVH passage discusses cardiovascular risk in relation to overall cardiovascular health, while the clinical-guidelines passage discusses risk-factor scoring. Neither addresses semaglutide, whether event reduction preceded clinically significant weight loss, or whether it varied by weight loss achieved; searches for those terms found no supporting passage in our copy. (LLM, conf=0.78)
Experimental — accuracy not yet measuredSome cardiovascular benefits of semaglutide are weight-independent.
“indicating some cardiovascular benefits that are weight-independent”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
The advisory’s Clinical Statements and Guidelines section (p. e28) discusses cardiovascular-health scoring for blood glucose and blood pressure, not semaglutide’s effects. Searches for semaglutide and weight-independent cardiovascular benefits found no passage in our copy addressing the claim. (LLM, conf=0.76)
Experimental — accuracy not yet measuredGLP-1-based therapy often causes significant weight loss and improvements in CKM risk profiles and MASLD, while SGLT2i has a marked impact on CKD.
“GLP-1–based therapy often causes significant weight loss and improvements in CKM risk profiles and MASLD, while SGLT2i has a marked impact on CKD.19–30”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
The Clinical Statements and Guidelines passages discuss cardiovascular-health scoring, including blood glucose, lipids, and treated values, but do not address the claimed treatment effects. Searches for GLP-1, SGLT2, MASLD, CKM, and CKD found no passage linking either therapy to the stated outcomes. (LLM, conf=0.75)
Experimental — accuracy not yet measuredBoth SGLT2i and GLP-1-based therapy improve kidney outcomes, with GLP-1-based therapy additionally promoting significant weight reduction and glycemic control (especially semaglutide and tirzepatide) and reducing liver fibrosis in MASH.
“Both SGLT2i and GLP-1–based therapy improve kidney outcomes,49–51 with GLP-1–based therapy additionally promoting significant weight reduction and glycemic control (especially semaglutide and tirzepatide)19–25 and reducing liver fibrosis in MASH”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
The advisory’s Clinical Statements and Guidelines section discusses blood-glucose scoring and metformin use (p. e28), but does not address GLP-1–based therapy’s effects on weight or glycemic control. Searches for semaglutide, tirzepatide, GLP-1 receptor agonists, kidney outcomes, and MASH found no passage substantiating the attributed treatment claims. (LLM, conf=0.76)
Experimental — accuracy not yet measuredIn patients with T2D and ASCVD, SGLT2i and GLP-1-based therapy significantly reduces the risk of MACE and cardiovascular mortality, promotes weight loss, and reduces progression of kidney disease.
“In patients with T2D and ASCVD, SGLT2i and GLP-1–based therapy significantly reduces the risk of MACE and cardiovascular mortality, promotes weight loss,34 and reduces progression of kidney disease”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [36]
Citation 34 is attached to the weight-loss portion of the sentence. The Clinical Statements and Guidelines passage (approximately p. e28) discusses blood-glucose scoring and metformin, but does not address weight loss from SGLT2 inhibitors or GLP-1–based therapy in patients with T2D and ASCVD. Searches for both drug classes and weight loss found no passage supporting that attributed point. (LLM, conf=0.76)
Experimental — accuracy not yet measuredSeveral trials corroborate the safety and efficacy of exercise training for HFpEF, but these did not exclusively recruit patients with obesity.
“Several trials corroborate the safety and efficacy of exercise training for HFpEF, but these did not exclusively recruit patients with obesity.21–23”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
The retrieved passages from the References section concern other cardiovascular and obesity interventions, not exercise training for HFpEF. Searches for HFpEF exercise-training safety and efficacy and for obesity-related recruitment found no passage addressing the claim. (LLM, conf=0.76)
Experimental — accuracy not yet measuredEvidence for GLP-1 benefit in HFpEF is growing, but efficacy and safety in HFrEF are less clear, with somewhat increased risk for adverse outcomes in small HFrEF trials.
“While there is growing evidence for GLP-1 benefit in HFpEF, there is less clarity regarding efficacy and safety in HFrEF, based on somewhat increased risk for adverse outcomes among patients taking GLP-1 RA in small HFrEF trials.19–21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
The Clinical Statements and Guidelines passages discuss cardiovascular-health scoring, including blood-glucose thresholds, not GLP-1 receptor agonist treatment in heart failure. Searches for GLP-1, HFpEF, HFrEF, and adverse outcomes in small trials found no passage in our copy addressing the claim. (LLM, conf=0.76)
Experimental — accuracy not yet measuredTwo high-quality simulation model-based cost-effectiveness analyses projected that adding SGLT2i therapy to prior GDMT in adults with symptomatic HFrEF was cost-effective from a US health care sector perspective and a lifetime analytic horizon, with an incremental cost-effectiveness ratio between $68 000 and $84 000 per QALY gained.
“Two high-quality simulation model–based cost-effectiveness analyses projected that adding SGLT2i therapy to prior GDMT in adults with symptomatic HFrEF was cost-effective from a US health care sector perspective and a lifetime analytic horizon,35,36 with an incremental cost-effectiveness ratio between $68 000 and $84 000 per QALY gained (assuming an annual drug cost of $4192 to $5684, which is con”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [36]
Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredIn adults with CKM syndrome stage 4 with CKD and symptomatic HF with LVEF ≤40%, addition of an SGLT2i prior to GDMT at 2025 US prices is projected to be cost-effective compared with prior GDMT.
“In adults with CKM syndrome stage 4 syndrome with CKD and symptomatic HF with LVEF ≤40%, addition of an SGLT2i prior to GDMT at 2025 US prices is projected to be cost-effective compared with prior GDMT.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [36]
The Clinical Statements and Guidelines passages address cardiovascular-health scoring, including blood glucose and blood pressure, not treatment cost-effectiveness. Searches for SGLT2i, CKM syndrome, heart failure and cost-effectiveness found no passage projecting an outcome for adding an SGLT2i to GDMT at 2025 US prices. (LLM, conf=0.78)
Experimental — accuracy not yet measuredNeither of the two SGLT2i cost-effectiveness studies specifically examined the subgroup of individuals with CKD.
“However, neither study specifically examined the subgroup of individuals with CKD.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [36]
The Clinical Statements and Guidelines passage (p. e28) discusses blood-glucose scoring and metformin, not SGLT2 inhibitor cost-effectiveness studies. Searches for SGLT2i, CKD, and cost-effectiveness found no passage assessing whether either study examined a CKD subgroup. (LLM, conf=0.76)
Experimental — accuracy not yet measuredIn probabilistic sensitivity analyses, the incremental cost-effectiveness ratio was <$120 000 per QALY gained in >95% of simulations in one analysis and approximately 70% in the other.
“In probabilistic sensitivity analyses, the incremental cost-effectiveness ratio was <$120 000 per QALY gained in >95% of the simulations in 1 analysis,35 and approximately 70% of the simulations in the other.36”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [36]
The Clinical Statements and Guidelines passages describe cardiovascular-health scoring, not probabilistic cost-effectiveness analyses. A search of our full-text copy for the $120,000-per-QALY threshold and the >95% and approximately 70% simulation results found no passage reporting them. (LLM, conf=0.77)
Experimental — accuracy not yet measuredAmong the 4 medication classes, 2 are kidney-protective: RASi and SGLT2i.
“Among these 4 medication classes (6 classes if the patient also self-identifies as Black race), 2 are kidney-protective; namely, 1) RASi, with ARNI having superior HF benefits over ACEi/ARB; and 2) SGLT2i.13,21–25”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
The Clinical Statements and Guidelines passage (p. e28) discusses scoring blood glucose and blood pressure, not kidney-protective heart-failure medications. Searches for RASi, SGLT2i, ARNI, and kidney protection found no passage in our copy addressing whether two of the four medication classes protect the kidneys. (LLM, conf=0.77)
Experimental — accuracy not yet measuredARNI has superior HF benefits over ACEi/ARB.
“RASi, with ARNI having superior HF benefits over ACEi/ARB; and 2) SGLT2i.13,21–25”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
The supplied passages from the References and Disclosures sections do not address heart-failure treatment comparisons. Further searches of our copy for ARNI, ACEi/ARB, and sacubitril/valsartan found no passage comparing their heart-failure benefits. (LLM, conf=0.76)
Experimental — accuracy not yet measuredAssessment of fibrosis risk starts with the FIB-4 index, with further sequential assessments as needed to rule out or rule in clinically significant fibrosis (≥ stage 2).
“Assessment of fibrosis risk starts with the FIB-4 index, with further sequential assessments as needed to rule out (or rule in) clinically significant fibrosis (≥ stage 2).19–21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
The Clinical Statements and Guidelines passages describe cardiovascular-health scoring, including blood glucose, blood pressure, and lipids. Searches for “FIB-4 index” and “liver fibrosis stage 2” found no passage addressing a sequential fibrosis-risk assessment or the ≥stage 2 threshold. (LLM, conf=0.77)
Experimental — accuracy not yet measuredMASLD is an independent risk factor for CVD morbidity and mortality.
“Moreover, it is an independent risk factor for CVD morbidity and mortality.36”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [36]
The Outcomes of CVH section discusses cardiovascular health scores and CVD events and mortality, not MASLD. Searches for MASLD, NAFLD, fatty liver, and steatotic liver disease found no passage in our copy addressing whether MASLD is an independent risk factor for CVD morbidity or mortality. (LLM, conf=0.78)
Experimental — accuracy not yet measuredDOACs offer advantages over VKAs: rapid onset, predictable effect, wider therapeutic window, no routine monitoring, and fewer food/drug interactions.
“DOACs offer advantages over VKAs: rapid onset, predictable effect, wider therapeutic window, no routine monitoring, and fewer food/drug interactions.21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
The paper’s ‘Updated Definitions and Novel Quantitative Assessment of CVH Metrics’ section discusses cardiovascular-health measures, including diet, rather than anticoagulant drugs. Searches for DOACs, VKAs, direct oral anticoagulants, warfarin, monitoring, and therapeutic windows found no passage comparing the drugs or describing the claimed advantages. (LLM, conf=0.76)
Experimental — accuracy not yet measuredIn stage G3 CKD, subgroup analyses suggest DOACs are noninferior to VKA for recurrent VTE or major bleeding.
“In stage G3 CKD (eGFR, 30–59 mL/min/1.73 m2), subgroup analyses suggest DOACs are noninferior to VKA for recurrent VTE or major bleeding.35–38”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [36]
The 'Outcomes of CVH' section discusses cardiovascular health and risk of end-stage renal disease, but not anticoagulant treatment in stage G3 CKD. Searches for DOACs versus VKA, recurrent VTE, major bleeding, and the stage G3 subgroup found no passage addressing the claim in our copy. (LLM, conf=0.78)
Experimental — accuracy not yet measuredDOAC kidney clearance varies: dabigatran 80%, edoxaban 50%, rivaroxaban 35%, apixaban 27%.
“DOAC kidney clearance varies (dabigatran 80%, edoxaban 50%, rivaroxaban 35%, apixaban 27%).21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [21]
The Clinical Statements and Guidelines passages discuss cardiovascular-health measures, including blood pressure and lipids, but do not address DOAC clearance. Searches of our copy for the four drugs and their percentages, and for renal elimination of direct oral anticoagulants, found no passage supporting the stated figures. (LLM, conf=0.76)
Experimental — accuracy not yet measuredThe CHAP trial demonstrated optimizing BP control during pregnancy to target <140/90 mm Hg was associated with lower risk of adverse maternal and fetal outcomes.
“The CHAP (Chronic Hypertension and Pregnancy) trial demonstrated that optimizing BP control during pregnancy to target <140/90 mm Hg was associated with lower risk of adverse maternal and fetal outcomes.36”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [36]
The Clinical Statements and Guidelines section discusses general BP scoring (p. e28), and the Policies section discusses maternal health, but neither reports results from the CHAP trial. Searches for CHAP and for pregnancy BP control below 140/90 mm Hg found no passage addressing the claimed maternal and fetal outcomes. (LLM, conf=0.74)
Experimental — accuracy not yet measuredMultiple RCTs of CKM therapies included albuminuria as an eligibility criterion, with absolute risk reductions for cardiovascular and kidney outcomes commonly greater for those with more baseline albuminuria.
“Multiple RCTs of CKM therapies included albuminuria as an eligibility criterion, with absolute risk reductions for cardiovascular and kidney outcomes commonly greater for those with more baseline albuminuria.12,15,33–38”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [36]
The Clinical Statements and Guidelines passage (p. e28) discusses scoring blood glucose and blood pressure, not albuminuria-based eligibility for CKM therapy trials. Searches for albuminuria, trial eligibility, and risk reductions found no passage in our copy addressing the attributed claim. (LLM, conf=0.76)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Chang, A. R., Cheng, S., Delling, F. N., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000757 · Cited by 9,175 · see citing works
Self-citationWhelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391 · see citing works
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000625 · Cited by 6,185 · see citing works
Self-citationHeart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001052 · Cited by 5,987 · see citing works
Self-citationHeart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association
Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Cheng, S., Delling, F. N., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000950 · Cited by 5,784 · see citing works
Self-citationLloyd-Jones, D. M., Hong, Y., Labarthe, D., Mozaffarian, D., Appel, L. J., Van Horn, L., Greenlund, K., Daniels, S., Nichol, G., Tomaselli, G. F., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.192703 · Cited by 4,750 · see citing works
Self-citationSleep Health: Can We Define It? Does It Matter?
Buysse, D. J. (2014) · SLEEP · doi:10.5665/sleep.3298 · Cited by 2,607 · see citing works
National Sleep Foundation’s updated sleep duration recommendations: final report
Hirshkowitz, M., Whiton, K., Albert, S. M., Alessi, C., Bruni, O., DonCarlos, L., Hazen, N., Herman, J., Adams Hillard, P. J., Katz, E. S., et al. (2015) · Sleep Health · doi:10.1016/j.sleh.2015.10.004 · Cited by 2,348 · see citing works
Sleep duration and all-cause mortality: a systematic review and meta-analysis of prospective studies
Cappuccio, F. P., D'Elia, L., Strazzullo, P., & Miller, M. A. (2010) · Sleep · doi:10.1093/sleep/33.5.585 · Cited by 2,224 · see citing works
Slavich, G. M., & Irwin, M. R. (2014) · Psychological Bulletin · doi:10.1037/a0035302 · Cited by 2,206 · see citing works
Watson, N. F., Badr, M. S., Belenky, G. L., Bliwise, D. L., Buxton, O. M., Buysse, D. J., Dinges, D. F., Gangwisch, J. E., Grandner, M. A., Kushida, C. A., et al. (2015) · SLEEP · doi:10.5665/sleep.4716 · Cited by 1,587 · see citing works
Self-citationParuthi, S., Brooks, L. J., D’Ambrosio, C., Hall, W. A., Kotagal, S., Lloyd, R. M., Malow, B. A., Maski, K., Nichols, C., Quan, S. F., et al. (2016) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.5866 · Cited by 1,562 · see citing works
Havranek, E. P., Mujahid, M. S., Barr, D. A., Blair, I. V., Cohen, M. S., Cruz-Flores, S., Davey-Smith, G., Dennison-Himmelfarb, C. R., Lauer, M. S., Lockwood, D. W., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000228 · Cited by 1,472 · see citing works
Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease
Khera, A. V., Emdin, C. A., Drake, I., Natarajan, P., Bick, A. G., Cook, N. R., Chasman, D. I., Baber, U., Mehran, R., Rader, D. J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1605086 · Cited by 1,460 · see citing works
Engaging patients to improve quality of care: a systematic review
Bombard, Y., Baker, G. R., Orlando, E., Fancott, C. A., Bhatia, P., Casalino, S., Oñate, K., Denis, J., & Pomey, M. (2018) · Implementation Science · doi:10.1186/s13012-018-0784-z · Cited by 1,312 · see citing works
Short sleep duration and health outcomes: a systematic review, meta-analysis, and meta-regression
Itani, O., Jike, M., Watanabe, N., & Kaneita, Y. (2017) · Sleep Medicine · doi:10.1016/j.sleep.2016.08.006 · Cited by 1,252 · see citing works
Insomnia as a predictor of mental disorders: a systematic review and meta-analysis
Hertenstein, E., Feige, B., Gmeiner, T., Kienzler, C., Spiegelhalder, K., Johann, A., Jansson-Fröjmark, M., Palagini, L., Rücker, G., Riemann, D., et al. (2019) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2018.10.006 · Cited by 1,201 · see citing works
Carnethon, M. R., Pu, J., Howard, G., Albert, M. A., Anderson, C. A. M., Bertoni, A. G., Mujahid, M. S., Palaniappan, L., Taylor, H. A., Willis, M., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000534 · Cited by 1,147 · see citing works
Self-citationSleep and mental disorders: a meta-analysis of polysomnographic research
Baglioni, C., Nanovska, S., Regen, W., Spiegelhalder, K., Feige, B., Nissen, C., Reynolds, C. F., & Riemann, D. (2016) · Psychological Bulletin · doi:10.1037/bul0000053 · Cited by 1,074 · see citing works
St-Onge, M.-P., Grandner, M. A., Brown, D., Conroy, M. B., Jean-Louis, G., Coons, M., & Bhatt, D. L. (2016) · Circulation · doi:10.1161/cir.0000000000000444 · Cited by 1,044 · see citing works
Self-citationChurchwell, K., Elkind, M. S. V., Benjamin, R. M., Carson, A. P., Chang, E. K., Lawrence, W., Mills, A., Odom, T. M., Rodriguez, C. J., Rodriguez, F., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000936 · Cited by 984 · see citing works
Sleep duration and mortality: a systematic review and meta-analysis
GALLICCHIO, L., & KALESAN, B. (2009) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2008.00732.x · Cited by 979 · see citing works
Levine, G. N., Cohen, B. E., Commodore-Mensah, Y., Fleury, J., Huffman, J. C., Khalid, U., Labarthe, D. R., Lavretsky, H., Michos, E. D., Spatz, E. S., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000947 · Cited by 865 · see citing works
Self-citationChurch-Based Health Promotion Interventions: Evidence and Lessons Learned
Campbell, M. K., Hudson, M. A., Resnicow, K., Blakeney, N. C., Paxton, A. E., & Baskin, M. L. (2006) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.28.021406.144016 · Cited by 847 · see citing works
Yin, J., Jin, X., Shan, Z., Li, S., Huang, H., Li, P., Peng, X., Peng, Z., Yu, K., Bao, W., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.005947 · Cited by 721 · see citing works
Grandner, M. A. (2017) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2016.10.012 · Cited by 720 · see citing works
Self-citationFolsom, A. R., Yatsuya, H., Nettleton, J. A., Lutsey, P. L., Cushman, M., & Rosamond, W. D. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.11.041 · Cited by 713 · see citing works
Self-citationAnothaisintawee, T., Reutrakul, S., Van Cauter, E., & Thakkinstian, A. (2016) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2015.10.002 · Cited by 640 · see citing works
Launching PCORnet, a national patient-centered clinical research network
Fleurence, R., Curtis, L. H., Califf, R. M., Platt, R., Selby, J. V., & Brown, J. S. (2014) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2014-002747 · Cited by 637 · see citing works
Grandner, M. A., Hale, L., Moore, M., & Patel, N. P. (2010) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2009.07.006 · Cited by 602 · see citing works
Self-citationMozaffarian, D., Afshin, A., Benowitz, N. L., Bittner, V., Daniels, S. R., Franch, H. A., Jacobs, D. R., Kraus, W. E., Kris-Etherton, P. M., Krummel, D. A., et al. (2012) · Circulation · doi:10.1161/cir.0b013e318260a20b · Cited by 601 · see citing works
A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops
Victor, R. G., Lynch, K., Li, N., Blyler, C. A., Muhammad, E., Handler, J., Brettler, J. W., Rashid, M. A., Hsu, B., Foxx-Drew, D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1717250 · Cited by 560 · see citing works
Principles And Practice Of Sleep Medicine
Ayvazian, L. F. (1989) · American Review of Respiratory Disease · doi:10.1164/ajrccm/140.4.1172a · Cited by 554 · see citing works
Burke, L. E., Ma, J., Azar, K. M. J., Bennett, G. G., Peterson, E. D., Zheng, Y., Riley, W., Stephens, J., Shah, S. H., Suffoletto, B., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000232 · Cited by 516 · see citing works
Branas, C. C., South, E. C., Kondo, M. C., Hohl, B. C., Bourgois, P. I., Wiebe, D. J., & MacDonald, J. M. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718503115 · Cited by 515 · see citing works
Sleep Health: An Opportunity for Public Health to Address Health Equity
Hale, L. E., Troxel, W., & Buysse, D. J. (2020) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-040119-094412 · Cited by 499 · see citing works
Bjørge, T., Tretli, S., & Engeland, A. (2004) · American Journal of Epidemiology · doi:10.1093/aje/ · Cited by 492 · see citing works
Sleep disparity, race/ethnicity, and socioeconomic position
Grandner, M. A., Williams, N. J., Knutson, K. L., Roberts, D., & Jean-Louis, G. (2016) · Sleep Medicine · doi:10.1016/j.sleep.2015.01.020 · Cited by 481 · see citing works
Self-citationMellen, P. B., Gao, S. K., Vitolins, M. Z., & Goff, D. C. (2008) · Archives of Internal Medicine · doi:10.1001/archinternmed.2007.119 · Cited by 444 · see citing works
Mass media interventions for smoking cessation in adults
Bała, M. M., Strzeszynski, L., & Topór‐Mądry, R. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004704.pub4 · Cited by 431 · see citing works
Reynolds, A. J., Temple, J. A., Ou, S., Arteaga, I. A., & White, B. A. B. (2011) · Science · doi:10.1126/science.1203618 · Cited by 424 · see citing works
Gorelick, P. B., Furie, K. L., Iadecola, C., Smith, E. E., Waddy, S. P., Lloyd-Jones, D. M., Bae, H.-J., Bauman, M. A., Dichgans, M., Duncan, P. W., et al. (2017) · Stroke · doi:10.1161/str.0000000000000148 · Cited by 411 · see citing works
Self-citationLobelo, F., Rohm Young, D., Sallis, R., Garber, M. D., Billinger, S. A., Duperly, J., Hutber, A., Pate, R. R., Thomas, R. J., Widlansky, M. E., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000559 · Cited by 402 · see citing works
South, E. C., Hohl, B. C., Kondo, M. C., MacDonald, J. M., & Branas, C. C. (2018) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.0298 · Cited by 399 · see citing works
Bhatnagar, A., Whitsel, L. P., Ribisl, K. M., Bullen, C., Chaloupka, F. J., Piano, M. R., Robertson, R. M., McAuley, T. R., Goff, D. C., & Benowitz, N. L. (2014) · Circulation · doi:10.1161/cir.0000000000000107 · Cited by 393 · see citing works
Shimbo, D., Artinian, N. T., Basile, J. N., Krakoff, L. R., Margolis, K. L., Rakotz, M. K., Wozniak, G., & On behalf of the American Heart Association and the American Medical Association (2020) · Circulation · doi:10.1161/cir.0000000000000803 · Cited by 389 · see citing works
Brown, H. L., Warner, J. J., Gianos, E., Gulati, M., Hill, A. J., Hollier, L. M., Rosen, S. E., Rosser, M. L., & Wenger, N. K. (2018) · Circulation · doi:10.1161/cir.0000000000000582 · Cited by 378 · see citing works
The 24-Hour Activity Cycle: A New Paradigm for Physical Activity
Rosenberger, M. E., Fulton, J. E., Buman, M. P., Troiano, R. P., Grandner, M. A., Büchner, D. M., & Haskell, W. L. (2018) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001811 · Cited by 378 · see citing works
Self-citationLiu, K., Daviglus, M. L., Loria, C. M., Colangelo, L. A., Spring, B., Moller, A. C., & Lloyd-Jones, D. M. (2012) · Circulation · doi:10.1161/circulationaha.111.060681 · Cited by 371 · see citing works
Self-citationBack to the Future: Achieving Health Equity Through Health Informatics and Digital Health
Brewer, L. C., Fortuna, K. L., Jones, C., Walker, R., Hayes, S. N., Patten, C. A., & Cooper, L. A. (2020) · JMIR mHealth and uHealth · doi:10.2196/14512 · Cited by 367 · see citing works
Self-citationSpencer, M. S., Rosland, A.-M., Kieffer, E. C., Sinco, B. R., Valerio, M., Palmisano, G., Anderson, M., Guzman, J. R., & Heisler, M. (2011) · American Journal of Public Health · doi:10.2105/ajph.2010.300106 · Cited by 357 · see citing works
Fifteen-Year Trends in Awareness of Heart Disease in Women
Mosca, L. J., Hammond, G., Greenberger, H. M., Towfighi, A., & Albert, M. A. (2013) · Circulation · doi:10.1161/cir.0b013e318287cf2f · Cited by 357 · see citing works
The Impact of Daily Sleep Duration on Health: A Review of the Literature
Alvarez, G. G., & Ayas, N. (2004) · Progress in Cardiovascular Nursing · doi:10.1111/j.0889-7204.2004.02422.x · Cited by 332 · see citing works
Gittelsohn, J., Rowan, M., & Gadhoke, P. (2012) · Preventing Chronic Disease · doi:10.5888/pcd9.110015 · Cited by 330 · see citing works
Mcmanus, R., Mant, J., Franssen, M., Nickless, A., Schwartz, C., Hodgkinson, J., Bradburn, P., Farmer, A. J., Grant, S., Greenfield, S., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30309-x · Cited by 330 · see citing works
Self-citationAchieving Health Equity: Closing The Gaps In Health Care Disparities, Interventions, And Research
Purnell, T. S., Calhoun, E. A., Golden, S. H., Halladay, J. R., Krok-Schoen, J. L., Appelhans, B. M., & Cooper, L. A. (2016) · Health Affairs · doi:10.1377/hlthaff.2016.0158 · Cited by 329 · see citing works
The “Million Hearts” Initiative — Preventing Heart Attacks and Strokes
Frieden, T. R., & Berwick, D. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmp1110421 · Cited by 310 · see citing works
von Philipsborn, P., Stratil, J. M., Burns, J., Busert, L. K., Pfadenhauer, L. M., Polus, S., Holzapfel, C., Hauner, H., & Rehfuess, E. A. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012292.pub2 · Cited by 306 · see citing works
Ideal Cardiovascular Health Is Inversely Associated With Incident Cancer
Rasmussen‐Torvik, L. J., Shay, C. M., Abramson, J. G., Friedrich, C. A., Nettleton, J. A., Prizment, A. E., & Folsom, A. R. (2013) · Circulation · doi:10.1161/circulationaha.112.001183 · Cited by 303 · see citing works
Liu, T.-Z., Xu, C., Rota, M., Cai, H., Zhang, C., Shi, M.-J., Yuan, R.-X., Weng, H., Meng, X.-Y., Kwong, J. S. W., et al. (2017) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2016.02.005 · Cited by 302 · see citing works
Huffman, M. D., Capewell, S., Ning, H., Shay, C. M., Ford, E. S., & Lloyd-Jones, D. M. (2012) · Circulation · doi:10.1161/circulationaha.111.070722 · Cited by 299 · see citing works
Self-citationThe links between sleep duration, obesity and type 2 diabetes mellitus
Antza, C., Kostopoulos, G., Mostafa, S., Nirantharakumar, K., & Tahrani, A. (2021) · Journal of Endocrinology · doi:10.1530/joe-21-0155 · Cited by 294 · see citing works
(2022) · Cineca Institutional Research Information System (Tor Vergata University) · doi:10.1161/circulationaha · Cited by 291 · see citing works
Xanthakis, V., Enserro, D. M., Murabito, J. M., Polak, J. F., Wollert, K. C., Januzzi, J. L., Wang, T. J., Tofler, G., & Vasan, R. S. (2014) · Circulation · doi:10.1161/circulationaha.114.009273 · Cited by 287 · see citing works
Pearson, T. A., Palaniappan, L. P., Artinian, N. T., Carnethon, M. R., Criqui, M. H., Daniels, S. R., Fonarow, G. C., Fortmann, S. P., Franklin, B. A., Galloway, J. M., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31828f8a94 · Cited by 251 · see citing works
A workshop report on the causes and consequences of sleep health disparities
Jackson, C. L., Walker, J. R., Brown, M. K., Das, R., & Jones, N. L. (2020) · SLEEP · doi:10.1093/sleep/zsaa037 · Cited by 227 · see citing works
Ideal cardiovascular health metrics and risk of cardiovascular disease or mortality: A meta-analysis
Fang, N., Jiang, M., & Fan, Y. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.03.210 · Cited by 221 · see citing works
Cardiovascular Health Disparities
Davis, A. M., Vinci, L. M., Okwuosa, T. M., Chase, A., & Huang, E. S. (2007) · Medical Care Research and Review · doi:10.1177/1077558707305416 · Cited by 215 · see citing works
Raghuveer, G., White, D. A., Hayman, L. L., Woo, J. G., Villafañe, J., Celermajer, D. S., Ward, K. D., de Ferranti, S. D., & Zachariah, J. P. V. (2016) · Circulation · doi:10.1161/cir.0000000000000443 · Cited by 214 · see citing works
Hasbani, N. R., Ligthart, S., Brown, M. R., Heath, A. S., Bebo, A., Ashley, K. E., Boerwinkle, E., Morrison, A. C., Folsom, A. R., Aguilar, D. A., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.053730 · Cited by 209 · see citing works
Healthy Lifestyle Change and Subclinical Atherosclerosis in Young Adults
Spring, B. J., Moller, A. C., Colangelo, L. A., Siddique, J., Roehrig, M., Daviglus, M. L., Polak, J. F., Reis, J. P., Sidney, S., & Liu, K. (2014) · Circulation · doi:10.1161/circulationaha.113.005445 · Cited by 202 · see citing works
The translational neuroscience of sleep: A contextual framework
Grandner, M. A., & Fernandez, F. (2021) · Science · doi:10.1126/science.abj8188 · Cited by 197 · see citing works
Self-citationBetter Population Health Through Behavior Change in Adults: A Call to Action
Spring, B., Ockene, J. K., Gidding, S. S., Mozaffarian, D., Moore, S., Rosal, M. C., Brown, M. D., Vafiadis, D. K., Cohen, D. L., Burke, L. E., et al. (2013) · Circulation · doi:10.1161/01.cir.0000435173.25936.e1 · Cited by 195 · see citing works
Self-citationAngell, S. Y., McConnell, M. V., Anderson, C. A. M., Bibbins-Domingo, K. B., Boyle, D. S., Capewell, S., Ezzati, M., de Ferranti, S. D., Gaskin, D. J., Goetzel, R. Z., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000758 · Cited by 193 · see citing works
Self-citationSleep Duration and Diabetes Risk: Population Trends and Potential Mechanisms
Grandner, M. A., Seixas, A. A., Shetty, S., & Shenoy, S. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0805-8 · Cited by 188 · see citing works
Self-citationWolfenden, L., Nathan, N., Sutherland, R., Yoong, S. L., Hodder, R. K., Wyse, R., Delaney, T. M., Grady, A., Fielding, A., Tzelepis, F., et al. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011677.pub2 · Cited by 176 · see citing works
Exercise to Improve Sleep in Insomnia: Exploration of the Bidirectional Effects
Baron, K., Reid, K., & Zee, P. (2013) · Journal of Clinical Sleep Medicine (JCSM) · doi:10.5664/jcsm.2930 · Cited by 175 · see citing works
Sosso, F. A. E., Holmes, S. D., & Weinstein, A. A. (2021) · Sleep Health · doi:10.1016/j.sleh.2021.05.005 · Cited by 174 · see citing works
Ideal Cardiovascular Health in Adolescence
Pahkala, K., Hietalampi, H., Laitinen, T. T., Viikari, J. S. A., Rönnemaa, T., Niinikoski, H., Lagström, H., Talvia, S. S., Jula, A., Heinonen, O. J., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.000761 · Cited by 168 · see citing works
MacArthur, G. J., Caldwell, D. M., Redmore, J., Watkins, S., Kipping, R., White, J., Chittleborough, C., Langford, R. M., Er, V., Lingam, R., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009927.pub2 · Cited by 163 · see citing works
Chastin, S., McGregor, D., Palarea-Albaladejo, J., Diaz, K. M., Hagströmer, M., Hallal, P. C., van Hees, V. T., Hooker, S., Howard, V. J., Lee, I.-M., et al. (2021) · British Journal of Sports Medicine · doi:10.1136/bjsports-2020-102345 · Cited by 162 · see citing works
Unger, E. D., Roux, A. V. D., Lloyd‐Jones, D. M., Mujahid, M. S., Nettleton, J. A., Bertoni, A. G., Badon, S. E., Ning, H., & Allen, N. B. (2014) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.113.000698 · Cited by 159 · see citing works
Self-citationPerak, A. M., Ning, H., Khan, S. S., Bundy, J. D., Allen, N. B., Lewis, C. E., Jacobs, D. R., Horn, L. V., & Lloyd‐Jones, D. M. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.10.002 · Cited by 156 · see citing works
Self-citationA Literature Synthesis of Health Promotion Research in Salons and Barbershops
Linnan, L. A., D’Angelo, H., & Harrington, C. B. (2014) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2014.02.007 · Cited by 150 · see citing works
Allen, N. B., Krefman, A. E., Labarthe, D. R., Greenland, P., Juonala, M., Kähönen, M. A. P., Lehtimäki, T. J., Day, R. S., Bazzano, L., Horn, L. V., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.0140 · Cited by 149 · see citing works
Self-citationEpigenetic Age Acceleration Reflects Long-Term Cardiovascular Health
Joyce, B. T., Gao, T., Zheng, Y., Ma, J., Hwang, S., Liu, L., Nannini, D. R., Horvath, S., Lu, A. T.-H., Allen, N. B., et al. (2021) · Circulation Research · doi:10.1161/circresaha.121.318965 · Cited by 141 · see citing works
Self-citationGrandner, M. A. (2020) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2020.02.017 · Cited by 139 · see citing works
Self-citationAdoption of Medicaid Expansion Is Associated with Lower Maternal Mortality
Eliason, E. L. (2020) · Women s Health Issues · doi:10.1016/j.whi.2020.01.005 · Cited by 138 · see citing works
Perak, A. M., Lancki, N., Kuang, A., Labarthe, D. R., Allen, N. B., Shah, S. H., Lowe, L. P., Grobman, W. A., Lawrence, J. M., Lloyd‐Jones, D. M., et al. (2021) · JAMA · doi:10.1001/jama.2021.0247 · Cited by 137 · see citing works
Self-citationMehta, L. S., Sharma, G. V., Creanga, A. A., Hameed, A. B., Hollier, L. M., Johnson, J. C., Leffert, L. R., McCullough, L. D., Mujahid, M. S., Watson, K. E., et al. (2021) · Circulation · doi:10.1161/cir.0000000000001000 · Cited by 136 · see citing works
Self-citationPetkovic, J., Duench, S., Trawin, J., Dewidar, O., Pardo, J. P., Simeon, R., DesMeules, M., Gagnon, D., Roberts, J. H., Hossain, A., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012932.pub2 · Cited by 133 · see citing works
Posttraumatic Stress Disorder and Inflammation: Untangling Issues of Bidirectionality
Sumner, J. A., Nishimi, K. M., Koenen, K. C., Roberts, A. L., & Kubzansky, L. D. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.11.005 · Cited by 131 · see citing works
Schoenthaler, A., Lancaster, K. J., Chaplin, W. F., Butler, M. J., Forsyth, J. M., & Ogedegbe, G. G. (2018) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.118.004691 · Cited by 126 · see citing works
Shen, X., Wu, Y., & Zhang, D. (2016) · Scientific Reports · doi:10.1038/srep21480 · Cited by 122 · see citing works
Rangaraj, V. R., & Knutson, K. L. (2016) · Sleep Medicine · doi:10.1016/j.sleep.2015.02.535 · Cited by 120 · see citing works
Synthetic nicotine has arrived
Jordt, S. (2021) · Tobacco Control · doi:10.1136/tobaccocontrol-2021-056626 · Cited by 120 · see citing works
The Association Between Sleep and Metabolic Syndrome: A Systematic Review and Meta-Analysis
Che, T., Cheng, Y. Z., Tian, D., Zhang, X., Liu, X., & Wu, Z. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.773646 · Cited by 118 · see citing works
Sleep Duration and Blood Pressure: Recent Advances and Future Directions
Makarem, N., Shechter, A., Carnethon, M. R., Mullington, J. M., Hall, M. H., & Abdalla, M. (2019) · Current Hypertension Reports · doi:10.1007/s11906-019-0938-7 · Cited by 117 · see citing works
State and Local Chronic Disease Surveillance Using Electronic Health Record Systems
Klompas, M., Cocoros, N. M., Menchaca, J. T., Erani, D., Hafer, E., Herrick, B., Josephson, M., Lee, M., Weiss, M. D. P., Zambarano, B., et al. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.303874 · Cited by 115 · see citing works
Effect of Sleep Disturbances on Blood Pressure
Makarem, N., Alcántara, C., Williams, N., Bello, N. A., & Abdalla, M. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.14479 · Cited by 114 · see citing works
Polonsky, T. S., Ning, H., Daviglus, M. L., Liu, K., Burke, G. L., Cushman, M., Eng, J., Folsom, A. R., Lutsey, P. L., Nettleton, J. A., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004894 · Cited by 113 · see citing works
Self-citationBhatnagar, A., Whitsel, L. P., Blaha, M. J., Huffman, M. D., Krishnan‐Sarin, S., Maa, J., Rigotti, N. A., Robertson, R. M., & Warner, J. J. (2019) · Circulation · doi:10.1161/cir.0000000000000669 · Cited by 110 · see citing works
Kris‐Etherton, P. M., Petersen, K. H., Després, J., Anderson, C. A. M., DEEDWANIA, P. C., Furie, K. L., Lear, S. A., Lichtenstein, A. H., Lobelo, F., Morris, P. B., et al. (2021) · Circulation · doi:10.1161/cir.0000000000001018 · Cited by 110 · see citing works
Self-citationREST/ACTIVITY RHYTHMS AND MORTALITY RATES IN OLDER MEN: MROS SLEEP STUDY
Paudel, M. L., Taylor, B. C., Ancoli‐Israel, S., BLACKWELL, T. L., Stone, K. L., Tranah, G. J., Redline, S. S., Cummings, S. R., Ensrud, K. E., & for the Osteoporotic Fractures in Men (MrOS) Study Group (2010) · Chronobiology International · doi:10.3109/07420520903419157 · Cited by 105 · see citing works
Increased Coronary Events in Depressed Cardiovascular Patients: 5-HT2A Receptor as Missing Link?
Schins, A., Honig, A., Crijns, H., Baur, L., & Hamulyák, K. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000088596.42029.10 · Cited by 103 · see citing works
Roger, V. L., Sidney, S. S., Fairchild, A. L., Howard, V. J., Labarthe, D. R., Shay, C. M., Tiner, A. C., Whitsel, L. P., & Rosamond, W. D. (2020) · Circulation · doi:10.1161/cir.0000000000000756 · Cited by 103 · see citing works
Self-citationCaleyachetty, R., Echouffo-Tcheugui, J. B., Muennig, P. A., Zhu, W., Muntner, P., & Shimbo, D. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.05.007 · Cited by 101 · see citing works
Sleep and cardiovascular disease: Emerging opportunities for psychology.
Hall, M. H., Brindle, R. C., & Buysse, D. J. (2018) · American Psychologist · doi:10.1037/amp0000362 · Cited by 98 · see citing works
Sleep Duration and Hypertension: Epidemiological Evidence and Underlying Mechanisms
Bock, J. M., Vungarala, S., Covassin, N., & Somers, V. K. (2021) · American Journal of Hypertension · doi:10.1093/ajh/hpab146 · Cited by 94 · see citing works
Schorr, E. N., Gepner, A. D., Dolansky, M. A., Forman, D. E., Park, L. G., Petersen, K., Still, C. H., Wang, T. Y., & Wenger, N. K. (2021) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/hcq.0000000000000103 · Cited by 90 · see citing works
Altered Blood Coagulation in Patients With Posttraumatic Stress Disorder
von Känel, R., Hepp, U., Buddeberg, C., Keel, M., Mica, L., Aschbacher, K., & Schnyder, U. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000221229.43272.9d · Cited by 86 · see citing works
Abnormal serum lipid profile in Brazilian police officers with post-traumatic stress disorder
Maia, D. B., Marmar, C. R., Mendlowicz, M. V., Metzler, T., Nóbrega, A., Peres, M. C., Coutinho, E. S., Volchan, E., & Figueira, I. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.08.013 · Cited by 86 · see citing works
Workplace Wellness Recognition for Optimizing Workplace Health
Fonarow, G. C., Calitz, C., Arena, R. A., Baase, C. M., Isaac, F. W., Lloyd‐Jones, D. M., Peterson, E. D., Pronk, N., Sánchez, E., Terry, P. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000206 · Cited by 86 · see citing works
Self-citationCardiovascular Health Among Pregnant Women, Aged 20 to 44 Years, in the United States
Perak, A. M., Ning, H., Khan, S. S., Horn, L. V., Grobman, W. A., & Lloyd‐Jones, D. M. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015123 · Cited by 86 · see citing works
Self-citationOgunmoroti, O., Osibogun, O. I., Spatz, E. S., Okunrintemi, V., Mathews, L. M., Ndumele, C. E., & Michos, E. D. (2021) · Preventive Medicine · doi:10.1016/j.ypmed.2021.106891 · Cited by 84 · see citing works
Sleep as a Target for Optimized Response to Smoking Cessation Treatment
Patterson, F., Grandner, M. A., Malone, S. K., Rizzo, A., Davey, A., & Edwards, D. G. (2017) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntx236 · Cited by 82 · see citing works
Self-citationChildhood lifestyle and clinical determinants of adult ideal cardiovascular health
Laitinen, T. T., Pahkala, K., Venn, A., Woo, J. G., Oikonen, M., Dwyer, T., Mikkilä, V., Hutri‐Kähönen, N., Smith, K. J., Gall, S., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.08.090 · Cited by 81 · see citing works
Sleep duration and risk of all-cause mortality: a systematic review and meta-analysis
García‐Perdomo, H. A., Zapata-Copete, J. A., & Cerón, C. A. R. (2018) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796018000379 · Cited by 79 · see citing works
Ayala, G. X., Baquero, B. I., Laraia, B. A., Ji, M., & Linnan, L. A. (2013) · Public Health Nutrition · doi:10.1017/s1368980013000955 · Cited by 78 · see citing works
Pahkala, K., Laitinen, T. T., Niinikoski, H., Kartiosuo, N., Rovio, S., Lagström, H., Loo, B.-M., Salo, P., Jokinen, E. V., Magnussen, C. G., et al. (2020) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(20)30059-6 · Cited by 78 · see citing works
Brewer, L. C., Balls‐Berry, J. E., Dean, P., Lackore, K. A., Jenkins, S. M., & Hayes, S. N. (2016) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-016-0226-z · Cited by 75 · see citing works
Self-citationEvaluation of a dietary screener: the M editerranean E ating P attern for A mericans tool
Cerwinske, L. A., Rasmussen, H. E., Lipson, S., Volgman, A. S., & Tangney, C. (2017) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12451 · Cited by 75 · see citing works
St‐Onge, M., & Zuraikat, F. M. (2019) · Current Atherosclerosis Reports · doi:10.1007/s11883-019-0772-z · Cited by 74 · see citing works
Palmer, K. N. B., Rivers, P. S., Melton, F. L., McClelland, D. J., Hatcher, J., Marrero, D. G., Thomson, C. A., & Garcia, D. O. (2021) · BMC Public Health · doi:10.1186/s12889-021-11584-0 · Cited by 74 · see citing works
Yang, X., Chen, H., Li, S., Pan, L., & Jia, C. (2015) · Heart Lung and Circulation · doi:10.1016/j.hlc.2015.08.005 · Cited by 73 · see citing works
Brewer, L. C., Redmond, N., Slusser, J. P., Scott, C. G., Chamberlain, A. M., Djoussé, L., Patten, C. A., Roger, V. L., & Sims, M. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.008855 · Cited by 72 · see citing works
Self-citationYoung, D. R., Cradock, A. L. I., Eyler, A. A., Fenton, M., Pedroso, M. S., Sallis, J. F., & Whitsel, L. P. (2020) · Circulation · doi:10.1161/cir.0000000000000878 · Cited by 72 · see citing works
Saiz, A. M., Aul, A. M., Malecki, K. M. C., Bersch, A. J., Bergmans, R. S., LeCaire, T. J., & Nieto, F. J. (2016) · Preventive Medicine · doi:10.1016/j.ypmed.2016.09.002 · Cited by 70 · see citing works
Lee, Y., Mozaffarian, D., Sy, S., Liu, J., Wilde, P., Marklund, M., Abrahams‐Gessel, S., Gaziano, T. A., & Micha, R. (2020) · Circulation · doi:10.1161/circulationaha.119.042956 · Cited by 70 · see citing works
Thorndike, A. N., Bright, O.-J. M., Dimond, M. A., Fishman, R., & Levy, D. E. (2016) · Public Health Nutrition · doi:10.1017/s1368980016003074 · Cited by 69 · see citing works
Association of cardiovascular health and epigenetic age acceleration
Pottinger, T. D., Khan, S. S., Zheng, Y., Zhang, W., Tindle, H. A., Allison, M., Wells, G., Shadyab, A. H., Nassir, R., Martin, L. W., et al. (2021) · Clinical Epigenetics · doi:10.1186/s13148-021-01028-2 · Cited by 69 · see citing works
Self-citationBundy, J. D., Zhu, Z., Ning, H., Zhong, V. W., Paluch, A. E., Wilkins, J. T., Lloyd‐Jones, D. M., Whelton, P. K., He, J., & Allen, N. B. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019681 · Cited by 68 · see citing works
Self-citationSocial Determinants of Suboptimal Cardiovascular Health Among Pregnant Women in the United States
Sharma, G. V., Grandhi, G. R., Acquah, I., Mszar, R., Mahajan, S., Khan, S. U., Javed, Z., Mehta, L. S., Gulati, M., Cainzos‐Achirica, M., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.022837 · Cited by 68 · see citing works
Self-citationWright, J. S., Wall, H. K., & Ritchey, M. D. (2018) · JAMA · doi:10.1001/jama.2018.13326 · Cited by 66 · see citing works
Gaye, B., Tajeu, G. S., Vasan, R. S., Lassale, C. M., Allen, N. B., Singh‐Manoux, A., & Jouven, X. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.017458 · Cited by 66 · see citing works
Self-citationMakarem, N., St‐Onge, M., Liao, M., Lloyd‐Jones, D. M., & Aggarwal, B. (2019) · Sleep Health · doi:10.1016/j.sleh.2019.05.005 · Cited by 65 · see citing works
Self-citationNeighborhood socioeconomic status and child sleep duration: A systematic review and meta-analysis
Tomfohr‐Madsen, L. M., Cameron, E. E., Dhillon, A. K., MacKinnon, A., Hernández, L., Madigan, S. L., & Tough, S. (2020) · Sleep Health · doi:10.1016/j.sleh.2020.02.012 · Cited by 64 · see citing works
He, M., Deng, X., Zhu, Y., Huan, L., & Niu, W. (2020) · BMC Public Health · doi:10.1186/s12889-020-09275-3 · Cited by 64 · see citing works
Gooding, H. C., Shay, C. M., Ning, H., Gillman, M. W., Chiuve, S. E., Reis, J. P., Allen, N. B., & Lloyd‐Jones, D. M. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002048 · Cited by 63 · see citing works
Self-citationAn Integrated Clinic-Community Partnership for Child Obesity Treatment: A Randomized Pilot Trial
Hoffman, J., Frerichs, L., Story, M. T., Jones, J., Gaskin, K., Apple, A., Skinner, A. C., & Armstrong, S. (2017) · PEDIATRICS · doi:10.1542/peds.2017-1444 · Cited by 60 · see citing works
Changes in Cardiovascular Health in the United States, 2003–2011
Pilkerton, C. S., Singh, S. S., Bias, T. K., & Frisbee, S. J. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001650 · Cited by 58 · see citing works
Brewer, L. C., Hayes, S. N., Jenkins, S. M., Lackore, K. A., Breitkopf, C. R., Cooper, L. A., & Patten, C. A. (2019) · Journal of General Internal Medicine · doi:10.1007/s11606-019-04936-5 · Cited by 56 · see citing works
Self-citationCardiovascular Health and Protection Against CVD
Lloyd‐Jones, D. M. (2014) · Circulation · doi:10.1161/circulationaha.114.012869 · Cited by 55 · see citing works
Self-citationImproving heart health among Black/African American women using civic engagement: a pilot study
Brown, A. G. M., Hudson, L. B., Chui, K. K. H., Metayer, N., Lebrón-Torres, N., Seguin‐Fowler, R. A., & Folta, S. C. (2017) · BMC Public Health · doi:10.1186/s12889-016-3964-2 · Cited by 55 · see citing works
Gao, X., Kershaw, K. N., Barber, S., Schreiner, P. J., Do, D. P., Roux, A. V. D., & Mujahid, M. S. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.023084 · Cited by 55 · see citing works
Lawman, H. G., Veur, S. S. V., Mallya, G. G., McCoy, T. A., Wojtanowski, A. C., Colby, L., Sanders, T. A., Lent, M. R., Sandoval, B., Sherman, S., et al. (2014) · Preventive Medicine · doi:10.1016/j.ypmed.2014.12.003 · Cited by 54 · see citing works
Skolarus, L. E., Cowdery, J. E., Dome, M. R., Bailey, S., Baek, J., Byrd, J. B., Hartley, S. E., Valley, S. C., Saberi, S., Wheeler, N. C., et al. (2017) · Health Promotion Practice · doi:10.1177/1524839917710893 · Cited by 53 · see citing works
Foraker, R. E., Bush, C. A., Greiner, M. A., Sims, M., Henderson, K., Smith, S. A., Bidulescu, A., Shoben, A. B., Hardy, N. C., & O'Brien, E. C. (2019) · Global Heart · doi:10.1016/j.gheart.2019.04.007 · Cited by 52 · see citing works
Self-citationHandbury, J., Rahkovsky, I. M., & Schnell, M. K. (2015) · National Bureau of Economic Research · doi:10.3386/w21126 · Cited by 50 · see citing works
Grandner, M. A. (2017) · Sleep Health · doi:10.1016/j.sleh.2017.07.014 · Cited by 48 · see citing works
Self-citationCardiovascular Health Status by Occupational Group — 21 States, 2013
Shockey, T. M., Sussell, A. L., & Odom, E. (2016) · MMWR Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6531a1 · Cited by 47 · see citing works
Diaz, C. L., Shah, N. S., Lloyd-Jones, D., & Khan, S. (2021) · JAMA cardiology · doi:10.1001/jamacardio.2021.1137 · Cited by 47 · see citing works
Self-citationLee, H., Yano, Y., Cho, S. M. J., Lee, H., Kim, D., Lloyd‐Jones, D. M., & Kim, H. C. (2021) · Circulation · doi:10.1161/circulationaha.121.054212 · Cited by 47 · see citing works
Self-citationTobacco-induced sleep disturbances: A systematic review and meta-analysis
Catoire, S., Nourredine, M., Lefebvre, S., Couraud, S., Gronfier, C., Rey, R., Peter‐Derex, L., Geoffroy, P. A., & Rolland, B. (2021) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2021.101544 · Cited by 47 · see citing works
A Multicomponent Behavioral Intervention to Reduce Stroke Risk Factor Behaviors
Brown, D. L., Conley, K. M., Sánchez, B. N., Resnicow, K., Cowdery, J. E., Sais, E., Murphy, J. B., Skolarus, L. E., Lisabeth, L. D., & Morgenstern, L. B. (2015) · Stroke · doi:10.1161/strokeaha.115.010678 · Cited by 46 · see citing works
Elgazzar, R., Nolan, T. S., Joseph, J. J., Aboagye-Mensah, E. B., Azap, R. A., & Gray, D. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0238374 · Cited by 46 · see citing works
Foraker, R. E., Benziger, C. P., DeBarmore, B. M., Cené, C. W., Loustalot, F. V., Khan, Y. M., Anderson, C. A. M., & Roger, V. L. (2020) · Circulation · doi:10.1161/cir.0000000000000913 · Cited by 46 · see citing works
Self-citationGaye, B., Tafflet, M., Arveiler, D., Montaye, M., Wagner, A., Ruidavets, J., Kee, F., Evans, A., Amouyel, P., Ferrières, J., et al. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.006389 · Cited by 45 · see citing works
Flórez, K. R., Payán, D. D., Palar, K., Williams, M. V., Katić, B., & Derose, K. P. (2019) · Nutrition Reviews · doi:10.1093/nutrit/nuz046 · Cited by 45 · see citing works
Kris-Etherton, P. M., Petersen, K. S., Després, J.-P., Braun, L., de Ferranti, S. D., Furie, K. L., Lear, S. A., Lobelo, F., Morris, P. B., Sacks, F. M., et al. (2021) · Circulation · doi:10.1161/cir.0000000000001014 · Cited by 43 · see citing works
Makarem, N., Sears, D. D., St‐Onge, M., Zuraikat, F. M., Gallo, L. C., Talavera, G. A., Castañeda, S. F., Lai, Y., Mi, J., & Aggarwal, B. (2020) · Nutrients · doi:10.3390/nu12103043 · Cited by 43 · see citing works
Islam, S. J., Kim, J. H., Baltrus, P., Topel, M. L., Liu, C., Ko, Y., Mujahid, M. S., Vaccarino, V., Sims, M., Mubasher, M., et al. (2020) · Annals of Epidemiology · doi:10.1016/j.annepidem.2020.11.009 · Cited by 43 · see citing works
Progress Toward Improved Cardiovascular Health in the United States
Pahigiannis, K., Thompson‐Paul, A. M., Barfield, W. L., Ochiai, E., Loustalot, F. V., Shero, S. T., & Hong, Y. (2019) · Circulation · doi:10.1161/circulationaha.118.035408 · Cited by 42 · see citing works
Realizing the Value of Community Health Workers — New Opportunities for Sustainable Financing
Lapidos, A., Lapedis, J., & Heisler, M. (2019) · New England Journal of Medicine · doi:10.1056/nejmp1815382 · Cited by 42 · see citing works
Lu, H., Yang, Q., Tian, F., Lyu, Y., He, H., Xin, X., & Zheng, X. (2021) · Journal of Diabetes Research · doi:10.1155/2021/8861038 · Cited by 42 · see citing works
The Cardiovascular Health of Young Adults: Disparities along the Urban-Rural Continuum
Lawrence, E., Hummer, R. A., & Harris, K. M. (2017) · The Annals of the American Academy of Political and Social Science · doi:10.1177/0002716217711426 · Cited by 41 · see citing works
Strong Hearts, Healthy Communities: A Community‐Based Randomized Trial for Rural Women
Seguin‐Fowler, R. A., Paul, L. C., Folta, S. C., Nelson, M. E., Strogatz, D. S., Graham, M. L., Diffenderfer, A., Eldridge, G. D., & Parry, S. A. (2018) · Obesity · doi:10.1002/oby.22158 · Cited by 41 · see citing works
Chattu, V. K., Chattu, S. K., Spence, D. W., Manzar, M. D., Burman, D., & Pandi-Perumal, S. R. (2019) · Journal of Racial and Ethnic Health Disparities · doi:10.1007/s40615-019-00607-7 · Cited by 40 · see citing works
Wang, L., Song, L., Li, D., Zhou, Z., Chen, S., Yang, Y., Hu, Y., Wang, Y., Wu, S., & Tian, Y. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.022502 · Cited by 40 · see citing works
Paek, H., Oh, H. J., Jung, Y., Thompson, T. L., Alaimo, K., Risley, J., & Mayfield, K. (2014) · Family & Community Health · doi:10.1097/fch.0000000000000014 · Cited by 39 · see citing works
Matthews, L. A., Rovio, S., Jaakkola, J., Niinikoski, H., Lagström, H., Jula, A., Viikari, J. S. A., Rönnemaa, T., Simell, O., Raitakari, O. T., et al. (2018) · European Journal of Clinical Nutrition · doi:10.1038/s41430-018-0350-4 · Cited by 39 · see citing works
Hossin, M. Z. (2016) · Sleep Health · doi:10.1016/j.sleh.2016.01.006 · Cited by 38 · see citing works
Whitaker, K. M., Jacobs, D. R., Kershaw, K. N., Demmer, R. T., Booth, J. N., Carson, A. P., Lewis, C. E., Goff, D. C., Lloyd‐Jones, D. M., Gordon‐Larsen, P., et al. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.03.017 · Cited by 38 · see citing works
Self-citationPsychological Well-being’s Link with Cardiovascular Health in Older Adults
Boehm, J. K., Soo, J., Chen, Y., Zevon, E. S., Hernandez, R., Lloyd-Jones, D., & Kubzansky, L. D. (2017) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.06.028 · Cited by 37 · see citing works
Self-citationWarner, J. J., Benjamin, I. J., Churchwell, K., Firestone, G., Gardner, T. J., Johnson, J. C., Ng-Osorio, J., Rodríguez, C. J., Todman, L., Yaffe, K. S., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000759 · Cited by 37 · see citing works
Lloyd‐Jones, D. M., Elkind, M. S. V., & Albert, M. A. (2021) · Circulation · doi:10.1161/circulationaha.121.057617 · Cited by 37 · see citing works
Self-citationJoseph, J. J., Nolan, T. S., Williams, A., McKoy, A., Zhao, S., Aboagye-Mensah, E. B., Kluwe, B., Odei, J. B., Brock, G. N., Lavender, D., et al. (2022) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2022.100315 · Cited by 36 · see citing works
Community-Based Participatory Research Principles for the African American Community
Smith, S. A., Whitehead, M. S., Sheats, J. Q., Ansa, B. E., Coughlin, S. S., & Blumenthal, D. S. (2015) · Journal of the Georgia Public Health Association · doi:10.20429/jgpha.2015.050122 · Cited by 35 · see citing works
Pienaar, P. R., Kolbe-Alexander, T. L., van Mechelen, W., Boot, C. R. L., Roden, L. C., Lambert, E. V., & Rae, D. E. (2021) · American Journal of Health Promotion · doi:10.1177/0890117121992288 · Cited by 35 · see citing works
Will Teens Go Red? Low Cardiovascular Disease Awareness Among Young Women
Gooding, H. C., Brown, C. A., Liu, J., Revette, A. C., Stamoulis, C., & de Ferranti, S. D. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011195 · Cited by 34 · see citing works
Influential Periods in Longitudinal Clinical Cardiovascular Health Scores
Krefman, A. E., Labarthe, D. R., Greenland, P., Pool, L. R., Aguayo, L., Juonala, M., Kähönen, M. A. P., Lehtimäki, T. J., Day, R. S., Bazzano, L., et al. (2021) · American Journal of Epidemiology · doi:10.1093/aje/kwab149 · Cited by 34 · see citing works
Self-citationCrook, E. D., Bryan, N. B., Hanks, R. S., Slagle, M. L., Morris, C. G., Ross, M. C., Torres, H., Williams, R., Voelkel, C., Walker, S., et al. (2009) · PubMed · Cited by 32 · see citing works
Foraker, R. E., Shoben, A. B., Kelley, M. M., Lai, A. M., Lopetegui, M. A., Jackson, R. D., Langan, M., & Payne, P. (2016) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2016.07.006 · Cited by 31 · see citing works
Self-citationMinkler, M., Estrada, J., Thayer, R., Juachon, L., Wakimoto, P., & Falbe, J. (2018) · Journal of Urban Health · doi:10.1007/s11524-018-0234-x · Cited by 31 · see citing works
Tubbs, A. S., Ghani, S. B., Valencia, D. Y., Jean‐Louis, G., Killgore, W. D. S., Fernandez, F., & Grandner, M. A. (2022) · Sleep Epidemiology · doi:10.1016/j.sleepe.2022.100022 · Cited by 31 · see citing works
Self-citationAllen, N. B., Lloyd‐Jones, D. M., Hwang, S., Rasmussen‐Torvik, L. J., Fornage, M., Morrison, A. C., Baldridge, A. S., Boerwinkle, E., Levy, D. A., Cupples, L. A., et al. (2016) · American Heart Journal · doi:10.1016/j.ahj.2015.12.022 · Cited by 28 · see citing works
Self-citationMobile health in preventive cardiology: current status and future perspective
Kozik, M., Isakadze, N., & Martin, S. S. (2021) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000891 · Cited by 27 · see citing works
Wensel, C. R., Trude, A. C. B., Poirier, L., Alghamdi, R., Trujillo, A. J., Steeves, E. A., Paige, D. A., & Gittelsohn, J. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16010064 · Cited by 25 · see citing works
Piedra, L. M., Andrade, F. C. D., Hernández, R., Perreira, K. M., Gallo, L. C., González, H. M., González, S. R., Cai, J., Chen, J., Castañeda, S. F., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.119.012704 · Cited by 25 · see citing works
Kim, J. H., Islam, S. J., Topel, M. L., Ko, Y.-A., Mujahid, M. S., Vaccarino, V., Liu, C., Sims, M., Mubasher, M., Searles, C. D., et al. (2020) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.120.006638 · Cited by 23 · see citing works
Actigraphy-Derived Sleep Is Associated with Eating Behavior Characteristics
Barragán, R., Zuraikat, F. M., Tam, V., Scaccia, S. E., Cochran, J., Li, S., Cheng, B., & St‐Onge, M. (2021) · Nutrients · doi:10.3390/nu13030852 · Cited by 23 · see citing works
Savin, K. L., Roesch, S. C., Oren, E., Carlson, J., Allison, M., Sotres‐Alvarez, D., Sallis, J. F., Jankowska, M. M., Talavera, G. A., Rodriguez, T. M., et al. (2021) · Social Science & Medicine · doi:10.1016/j.socscimed.2021.114496 · Cited by 21 · see citing works
The Strong Hearts, Healthy Communities Program 2.0: An RCT Examining Effects on Simple 7
Seguin‐Fowler, R. A., Strogatz, D. S., Graham, M. L., Eldridge, G. D., Marshall, G. A., Folta, S. C., Pullyblank, K. L., Nelson, M. E., & Paul, L. C. (2020) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2020.01.027 · Cited by 20 · see citing works
Dunn, C. G., Wilcox, S., Saunders, R. P., Kaczynski, A. T., Blake, C. E., & Turner‐McGrievy, G. M. (2020) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2020.05.014 · Cited by 20 · see citing works
Association of Socioeconomic Status With Ideal Cardiovascular Health in Black Men
Azap, R. A., Nolan, T. S., Gray, D. M., Lawson, K., Gregory, J. R., Capers, Q., Odei, J. B., & Joseph, J. J. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.020184 · Cited by 20 · see citing works
The Benefits of Medicaid Expansion
Buchmueller, T. C., Cliff, B. Q., & Levy, H. G. (2020) · JAMA Health Forum · doi:10.1001/jamahealthforum.2020.0879 · Cited by 19 · see citing works
Liu, M., Kou, F., Yang, S., Wang, S., He, Y., & Zhang, W. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.603877 · Cited by 19 · see citing works
Stecker, E. C., Ayanian, J. Z., & Fendrick, A. M. (2015) · Circulation · doi:10.1161/circulationaha.114.012584 · Cited by 18 · see citing works
Health for Hearts United Longitudinal Trial: Improving Dietary Behaviors in Older African Americans
Ralston, P. A., Wickrama, K. A. S., Coccia, C. C., Lemacks, J. L., Young‐Clark, I., & Ilich, J. Z. (2019) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2019.09.024 · Cited by 18 · see citing works
Turner, J. R., Smith, J., Bryant, K., Haynes, T., Stewart, M. K., Kuo, D. Z., Harris, K., McCoy, S., Lovelady, N. N., Sullivan, G., et al. (2017) · Progress in community health partnerships · doi:10.1353/cpr.2017.0010 · Cited by 17 · see citing works
Flagged first, then by citations
Research works printed but not linked: 2
- [24]24. Allen NB, Hwang S-J, Cupples LA, Levy D, Fox C, O'Donnell C, Lloyd-Jones D. The heritability of ideal cardiovascular health: the Framingham Heart Study. Circulation. 2010;122:A17245-A17245. Abstract 17245.
- [120]120. Eunice Kennedy Shriver National Institute of Child Health and Human Development. How much sleep do I need? Accessed January 31, 2022. https://www.nichd.nih.gov/health/topics/sleep/conditioninfo/how-much 127. American Heart Association. Go Red for Women. 2022. Accessed January 10, 2022. https://www.goredforwomen.org/ Downloaded from http://ahajournals.org by on September 1, 2023 August 2, 2022 Circulation. 2022;146:e18-e43. DOI: 10.1161/CIR.0000000000001078 e40 Lloyd-Jones et al Life's Essential 8 CLINICAL STATEMENTS AND GUIDELINES 128.
Cited by
Sorted by citations
Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001123 · Cited by 8,300 · see citing works
Self-citationMartin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001209 · Cited by 2,800 · see citing works
Self-citationCardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association
Ndumele, C. E., Rangaswami, J., Chow, S. L., Neeland, I. J., Tuttle, K. R., Khan, S. S., Coresh, J., Mathew, R. O., Baker-Smith, C. M., Carnethon, M. R., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001184 · Cited by 2,208 · see citing works
Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001168 · Cited by 1,598 · see citing works
Self-citationNdumele, C. E., Neeland, I. J., Tuttle, K. R., Chow, S. L., Mathew, R. O., Khan, S. S., Coresh, J., Baker-Smith, C. M., Carnethon, M. R., Després, J.-P., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001186 · Cited by 1,405 · see citing works
Martin, S. S., Aday, A. W., Allen, N. B., Almarzooq, Z., Anderson, C. A. M., Arora, P. K., Avery, C. L., Baker-Smith, C. M., Bansal, N., Beaton, A., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001303 · Cited by 1,206 · see citing works
Self-citationKhan, S. S., Coresh, J., Pencina, M. J., Ndumele, C. E., Rangaswami, J., Chow, S. L., Palaniappan, L. P., Sperling, L. S., Virani, S. S., Ho, J. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001191 · Cited by 797 · see citing works
Self-citationVirani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.04.003 · Cited by 596 · see citing works
Self-citationLloyd-Jones, D. M., Ning, H., Labarthe, D., Brewer, L., Sharma, G., Rosamond, W., Foraker, R. E., Black, T., Grandner, M. A., Allen, N. B., et al. (2022) · Circulation · doi:10.1161/circulationaha.122.060911 · Cited by 480 · see citing works
Self-citationBushnell, C., Kernan, W. N., Sharrief, A. Z., Chaturvedi, S., Cole, J. W., Cornwell, W. K., Cosby-Gaither, C., Doyle, S., Goldstein, L. B., Lennon, O. C., et al. (2024) · Stroke · doi:10.1161/str.0000000000000475 · Cited by 408 · see citing works
Maddox, K. E. J., Elkind, M. S. V., Aparicio, H. J., Commodore-Mensah, Y. Y., de Ferranti, S. D., Dowd, W. N., Hernandez, A. F., Khavjou, O., Michos, E. D., Palaniappan, L. P., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001256 · Cited by 397 · see citing works
Jones, D. W., Ferdinand, K. C., Taler, S. J., Johnson, H. M., Shimbo, D., Abdalla, M., Altieri, M. M., Bansal, N., Bello, N. A., Bress, A. P., et al. (2025) · Hypertension · doi:10.1161/hyp.0000000000000249 · Cited by 386 · see citing works
Self-citationEpidemiology and modifiable risk factors for atrial fibrillation
Elliott, A. D., Middeldorp, M. E., Gelder, I. C. V., Albert, C. M., & Sanders, P. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00820-8 · Cited by 380 · see citing works
Kazi, D. S., Elkind, M. S. V., Deutsch, A. F., Dowd, W. N., Heidenreich, P. A., Khavjou, O., Mark, D. B., Mussolino, M. E., Ovbiagele, B. I., Patel, S. S., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001258 · Cited by 369 · see citing works
Cardiovascular-Kidney-Metabolic (CKM) syndrome: A state-of-the-art review
Sebastian, S. A., Padda, I., & Johal, G. (2023) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2023.102344 · Cited by 362 · see citing works
Brown, T. M., Pack, Q. R., Aberegg, E., Brewer, L. C., Ford, Y. R., Forman, D. E., Gathright, E. C., Khadanga, S., Ozemek, C., & Thomas, R. J. (2024) · Circulation · doi:10.1161/cir.0000000000001289 · Cited by 346 · see citing works
Self-citationPalaniappan, L. P., Allen, N. B., Almarzooq, Z., Anderson, C. A. M., Arora, P. K., Avery, C. L., Baker-Smith, C. M., Bansal, N., Currie, M. E., Earlie, R. S., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001412 · Cited by 312 · see citing works
Self-citation2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia
Blumenthal, R. S., Morris, P. B., Gaudino, M., Johnson, H. M., Anderson, T. S., Bittner, V. A., Blankstein, R., Brewer, L. C., Cho, L., de Ferranti, S. D., et al. (2026) · JACC · doi:10.1016/j.jacc.2025.11.016 · Cited by 304 · see citing works
Self-citationJones, D. W., Ferdinand, K. C., Taler, S. J., Johnson, H. M., Shimbo, D., Abdalla, M., Altieri, M. M., Bansal, N., Bello, N. A., Bress, A. P., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001356 · Cited by 295 · see citing works
Self-citationPaluch, A. E., Boyer, W. R., Franklin, B. A., Laddu, D., Lobelo, F., Lee, D.-C., McDermott, M. M., Swift, D. L., Webel, A. R., Lane, A., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001189 · Cited by 290 · see citing works
Jones, D. W., Ferdinand, K. C., Taler, S. J., Johnson, H. M., Shimbo, D., Abdalla, M., Altieri, M. M., Bansal, N., Bello, N. A., Bress, A. P., et al. (2025) · JACC · doi:10.1016/j.jacc.2025.05.007 · Cited by 280 · see citing works
Self-citationSun, J.-H., Li, Y.-Z., Zhao, M., Yu, X., Zhang, C., Magnussen, C., & Xi, B. (2023) · BMC Medicine · doi:10.1186/s12916-023-02824-8 · Cited by 241 · see citing works
Trends in Cardiovascular Disease Mortality Rates and Excess Deaths, 2010–2022
Woodruff, R. C., Tong, X., Khan, S. S., Shah, N. S., Jackson, S. L., Loustalot, F. V., & Vaughan, A. S. (2023) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2023.11.009 · Cited by 272 · see citing works
Stress and cardiovascular disease: an update
Vaccarino, V., & Bremner, J. D. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01024-y · Cited by 268 · see citing works
Gottesman, R. F., Lutsey, P. L., Benveniste, H., Brown, D. L., Full, K. M., Lee, J., Osorio, R. S., Pase, M. P., Redeker, N. S., Redline, S. S., et al. (2024) · Stroke · doi:10.1161/str.0000000000000453 · Cited by 263 · see citing works
Arterial stiffness and vascular aging: mechanisms, prevention, and therapy
Herzog, M. J., Müller, P., Lechner, K., Stiebler, M., Arndt, P., Kunz, M., Ahrens, D., Schmeißer, A., Schreiber, S., & Braun-Dullaeus, R. C. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02346-0 · Cited by 246 · see citing works
Social Determinants of Health and Disparities in Hypertension and Cardiovascular Diseases
Chaturvedi, A., Zhu, A., Gadela, N. V., Prabhakaran, D., & Jafar, T. H. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21354 · Cited by 241 · see citing works
Lewey, J., Beckie, T. M., Brown, H. L., Brown, S. D., Garovic, V. D., Khan, S. S., Miller, E. C., Sharma, G., Mehta, L. S., & on behalf of the American Heart Association Cardiovascular Disease and Stroke in Women and Underrepresented Populations Committee of the Council on Clinical Cardiology; Council on Cardiopulmonary, C. C. (2024) · Circulation · doi:10.1161/cir.0000000000001212 · Cited by 229 · see citing works
Self-citationJCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Kitai, T., Kohsaka, S., Kato, T., Kato, E. T., Sato, K., TERAMOTO, K., Yaku, H., Akiyama, E., Ando, M., Izumi, C., et al. (2025) · Circulation Journal · doi:10.1253/circj.cj-25-0002 · Cited by 227 · see citing works
Benjafield, A., Kuniyoshi, F. H. S., Malhotra, A., Martin, J. L., Morin, C. M., Maurer, L., Cistulli, P. A., Pépin, J., & Wickwire, E. M. (2025) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2025.102121 · Cited by 217 · see citing works
A Heart-Healthy Diet for Cardiovascular Disease Prevention: Where Are We Now?
Diab, A., Dastmalchi, L. N., Gulati, M., & Michos, E. D. (2023) · Vascular Health and Risk Management · doi:10.2147/vhrm.s379874 · Cited by 202 · see citing works
Depressive Symptoms and Mortality Among US Adults
Zhang, Z., Jackson, S. L., Gillespie, C., Merritt, R. K., & Yang, Q. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.37011 · Cited by 197 · see citing works
Physical Activity Over the Lifecourse and Cardiovascular Disease
Perry, A., Dooley, E. E., Master, H., Spartano, N. L., Brittain, E. L., & Gabriel, K. P. (2023) · Circulation Research · doi:10.1161/circresaha.123.322121 · Cited by 195 · see citing works
Mehta, L. S., Velarde, G., Lewey, J., Sharma, G. V., Bond, R. M., Navas‐Acién, A., Fretts, A. M., Magwood, G., Yang, E., Blumenthal, R. S., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001139 · Cited by 193 · see citing works
Self-citationThe impact of population ageing on the burden of chronic kidney disease
Chesnaye, N. C., Ortíz, A., Zoccali, C., Stel, V. S., & Jager, K. J. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00863-9 · Cited by 185 · see citing works
Wang, X., Ma, H., Li, X., Heianza, Y., Manson, J. E., Franco, O. H., & Qi, L. (2023) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2023.0015 · Cited by 184 · see citing works
Cardiovascular Health and Life Expectancy Among Adults in the United States
Ma, H., Wang, X., Xue, Q., Li, X., Liang, Z., Heianza, Y., Franco, O. H., & Qi, L. (2023) · Circulation · doi:10.1161/circulationaha.122.062457 · Cited by 172 · see citing works
Cardiovascular Disease and Alzheimer's Disease: The Heart–Brain Axis
Saeed, A., López, O., Cohen, A. D., & Reis, S. (2023) · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · doi:10.1161/jaha.123.030780 · Cited by 138 · see citing works
Interactions of Obstructive Sleep Apnea With the Pathophysiology of Cardiovascular Disease, Part 1
Javaheri, S., Javaheri, S., Somers, V. K., Gozal, D., Mokhlesi, B., Mehra, R., McNicholas, W. T., Zee, P. C., Campos‐Rodríguez, F., Martínez‐García, M. Á., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.02.059 · Cited by 157 · see citing works
Khan, S. S., Brewer, L. C., Canobbio, M. M., Cipolla, M. J., Grobman, W. A., Lewey, J., Michos, E. D., Miller, E. C., Perak, A. M., Wei, G. S., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001124 · Cited by 156 · see citing works
Self-citationThe Role of Psychosocial Stress on Cardiovascular Disease in Women
Ebong, I., Quesada, O., Fonkoue, I. T., Mattina, D. J., Sullivan, S. M., de Oliveira, G. M. M., Spikes, T. A., Sharma, J., Commodore-Mensah, Y. Y., Ogunniyi, M. O., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.05.016 · Cited by 141 · see citing works
The Role of Sleep in Cardiovascular Disease
Jaspan, V. N., Greenberg, G. S., Parihar, S., Park, C. M., Somers, V. K., Shapiro, M. D., Lavie, C. J., Virani, S. S., & Slipczuk, L. N. (2024) · Current Atherosclerosis Reports · doi:10.1007/s11883-024-01207-5 · Cited by 140 · see citing works
Kwan, T., Wong, S. S., Hong, Y., Kanaya, A. M., Khan, S. S., Hayman, L. L., Shah, S. H., Welty, F. K., DEEDWANIA, P. C., Khaliq, A., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001145 · Cited by 139 · see citing works
Life’s Essential 8, Genetic Susceptibility, and Incident Cardiovascular Disease: A Prospective Study
Li, X., Ma, H., Wang, X., Feng, H., & Qi, L. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.319290 · Cited by 131 · see citing works
Cacciatore, S., Mao, S., Nuñez, M. V., Massaro, C., Spadafora, L., Bernardi, M., Perone, F., Sabouret, P. F., Biondi‐Zoccai, G., Banach, M., et al. (2025) · Aging Clinical and Experimental Research · doi:10.1007/s40520-025-03052-1 · Cited by 129 · see citing works
Kirkpatrick, C. F., Sikand, G., Petersen, K. S., Anderson, C. A. M., Aspry, K. E., Bolick, J. P., Kris‐Etherton, P. M., & Maki, K. C. (2023) · Journal of clinical lipidology · doi:10.1016/j.jacl.2023.05.099 · Cited by 128 · see citing works
Self-citationIsiozor, N. M., Kunutsor, S. K., Voutilainen, A., & Laukkanen, J. A. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad040 · Cited by 127 · see citing works
Sleep Architecture, Obstructive Sleep Apnea, and Cognitive Function in Adults
Pase, M. P., Harrison, S. L., Misialek, J. R., Kline, C. E., Cavuoto, M. G., Baril, A., Yiallourou, S. R., Bisson, A., Himali, D., Leng, Y., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.25152 · Cited by 127 · see citing works
The Importance of Nutrition in Menopause and Perimenopause—A Review
Erdélyi, A., Pálfi, E., Tűű, L., Nas, K., Szűcs, Z., Török, M., Jakab, A., & Várbı́ró, S. (2023) · Nutrients · doi:10.3390/nu16010027 · Cited by 127 · see citing works
St‐Onge, M., Aggarwal, B., Fernández‐Mendoza, J., Johnson, D. A., Kline, C. E., Knutson, K. L., Redeker, N. S., & Grandner, M. A. (2025) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/hcq.0000000000000139 · Cited by 127 · see citing works
Self-citationYi, J., Wang, L., Guo, X., & Ren, X. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.01.021 · Cited by 123 · see citing works
Xing, A., Tian, X., Wang, Y., Chen, S., Xu, Q., Xia, X., Zhang, Y., Zhang, X., Wang, A., & Wu, S. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad033 · Cited by 123 · see citing works
Writing Committee Members, Blumenthal, R. S., Morris, P. B., Gaudino, M., Johnson, H. M., Anderson, T. S., Bittner, V. A., Blankstein, R., Brewer, L. C., Cho, L., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001423 · Cited by 122 · see citing works
Self-citationAssociations between life’s essential 8 and non-alcoholic fatty liver disease among US adults
Wang, L., Yi, J., Guo, X., & Ren, X. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03839-0 · Cited by 120 · see citing works
Rempakos, A., Prescott, B. R., Mitchell, G. F., Vasan, R. S., & Xanthakis, V. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.030764 · Cited by 116 · see citing works
Petermann-Rocha, F. E., Deo, S. V., Celis-Morales, C. A., Ho, F. K. W., Bahuguna, P., McAllister, D., Sattar, N. A., & Pell, J. P. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101540 · Cited by 112 · see citing works
Strengthening the Pillars of Cardiovascular Health: Psychological Health is a Crucial Component
Gaffey, A. E., Rollman, B. L., & Burg, M. M. (2024) · Circulation · doi:10.1161/circulationaha.123.066132 · Cited by 112 · see citing works
Consumer Wearable Health and Fitness Technology in Cardiovascular Medicine
Petek, B. J., Al‐Alusi, M. A., Moulson, N., Grant, A. J., Besson, C., Guseh, J. S., Wasfy, M. M., Grémeaux, V., Churchill, T. W., & Baggish, A. L. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.04.054 · Cited by 106 · see citing works
Healthy dietary patterns and the risk of individual chronic diseases in community-dwelling adults
Shang, X., Liu, J., Zhu, Z., Zhang, X., Huang, Y., Liu, S., Wang, W., Zhang, X., Tang, S., Hu, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42523-9 · Cited by 106 · see citing works
Cardiac Contributions to Brain Health: A Scientific Statement From the American Heart Association
Testai, F. D., Gorelick, P. B., Chuang, P., Dai, X., Furie, K. L., Gottesman, R. F., Iturrizaga, J. C., Lazar, R. M., Russo, A. M., Seshadri, S. S., et al. (2024) · Stroke · doi:10.1161/str.0000000000000476 · Cited by 106 · see citing works
Sleep Deprivation, Sleep Disorders, and Chronic Disease
Ramos, A. R., Wheaton, A. G., & Johnson, D. A. (2023) · Preventing Chronic Disease · doi:10.5888/pcd20.230197 · Cited by 105 · see citing works
Long-term use of benzodiazepines in chronic insomnia: a European perspective
Soyka, M., Wild, I., Caulet, B., Leontiou, C., Lugoboni, F., & Hajak, G. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1212028 · Cited by 104 · see citing works
Gumz, M. L., Shimbo, D., Abdalla, M., Balijepalli, R. C., Benedict, C., Chen, Y., Earnest, D. J., Gamble, K. L., Garrison, S., Gong, M. C., et al. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19372 · Cited by 103 · see citing works
Mendoza, K., Smith-Warner, S. A., Rossato, S. L., Khandpur, N., Manson, J. E., Qi, L., Rimm, E. B., Mukamal, K. J., Willett, W. C., Wang, M., et al. (2024) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2024.100859 · Cited by 101 · see citing works
Zhang, J., Chen, G., Habudele, Z., Wang, X., Cai, M., Li, H., Gao, Y., Lip, G. Y. H., & Lin, H. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad179 · Cited by 101 · see citing works
Association between life’s essential 8 and biological ageing among US adults
Zhang, R., Wu, M., Zhang, W., Liu, X., Pu, J., Tao, W. Y., Zhu, Z., Tang, Z., Wei, N., Лю, Б., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04495-8 · Cited by 101 · see citing works
Obstructive Sleep Apnea and Cardiometabolic Disease: Obesity, Hypertension, and Diabetes
Tasali, E., Pamidi, S., Covassin, N., & Somers, V. K. (2025) · Circulation Research · doi:10.1161/circresaha.125.325676 · Cited by 100 · see citing works
Gordon, N. P., Yao, J., Brickner, L. A., & Lo, J. C.-M. (2022) · BMC Public Health · doi:10.1186/s12889-022-14443-8 · Cited by 98 · see citing works
Life’s Essential 8 and Risk of Stroke: A Prospective Community-Based Study
Wu, S., Wu, Z., Yu, D., Chen, S., Wang, A., Wang, A., & Gao, X. (2023) · Stroke · doi:10.1161/strokeaha.123.042525 · Cited by 97 · see citing works
Cumulative Incidence of Mortality Associated with Cardiovascular–Kidney–Metabolic (CKM) Syndrome
Claudel, S. E., Schmidt, I. M., Waikar, S. S., & Verma, A. (2025) · Journal of the American Society of Nephrology · doi:10.1681/asn.0000000637 · Cited by 98 · see citing works
The menopausal transition period and cardiovascular risk
Mehta, J. M., & Manson, J. E. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00926-7 · Cited by 96 · see citing works
Brazilian Guidelines of Hypertension – 2025
Brandão, A. A., Rodrigues, C. I. S., Bortolotto, L. A., Armstrong, A. D. C., Mulinari, R. A., Feitosa, A. D. M., Gomes, M. A. M., Barbosa, E. C. D., Moura-Neto, J. A., Neves, M. F., et al. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250624 · Cited by 99 · see citing works
AHA Life's essential 8 and ideal cardiovascular health among young adults
Shetty, N. S., Parcha, V., Patel, N., Yadav, I. S., Basetty, C. R., Li, C., Pandey, A., Kalra, R., Li, P., Arora, G., et al. (2022) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2022.100452 · Cited by 95 · see citing works
International Clinical Practice Guideline Recommendations for Acute Pulmonary Embolism
Zuin, M., Bikdeli, B., Ballard‐Hernandez, J., Barco, S., Battinelli, E. M., Giannakoulas, G. A., Jiménez, D., Klok, F. A., Krishnathasan, D., Lang, I. M., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.07.044 · Cited by 93 · see citing works
He, P., Zhang, Y., Ye, Z., Li, H., Liu, M., Zhou, C., Yang, S., Gan, X., Zhang, Y., & Qin, X. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155643 · Cited by 92 · see citing works
Zheng, G., Jin, J., Wang, F., Zheng, Q., Shao, J., Yao, J., Huang, P., Zhou, H., & Zhou, J. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02589-9 · Cited by 92 · see citing works
Ndumele, C. E., Rodriguez, F., Dixon, D. L., Khan, S. S., Mukherjee, D., Bajaj, M., Bangalore, S., Bozkurt, B., Breathett, K., Clarke, S. L., et al. (2026) · JACC · doi:10.1016/j.jacc.2026.03.056 · Cited by 90 · see citing works
Lee, D.-C., Brellenthin, A. G., Lanningham-Foster, L. M., Kohut, M. L., & Li, Y. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehad827 · Cited by 89 · see citing works
“10,11,14,22 Because the exact relative importance of each CVD risk factor was unclear in this specific population, we used the unweighted average of the four CVD risk factors, which is also common for a composite CVD risk score generation.”
MethodHe, J., Bundy, J. D., Geng, S., Tian, L., He, H., Li, X., Ferdinand, K. C., Anderson, A. H., DORANS, K. S., Vasan, R. S., et al. (2023) · Annals of Internal Medicine · doi:10.7326/m23-0507 · Cited by 85 · see citing works
Ndumele, C. E., Rodríguez, F., Dixon, D. L., Khan, S. S., Mukherjee, D., Bajaj, M. S., Bangalore, S., Bozkurt, B., Breathett, K. K., Clarke, S. L., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001453 · Cited by 87 · see citing works
Life's Essential 8 and the risk of cardiovascular disease: a systematic review and meta-analysis
Sebastian, S. A., Shah, Y., Paul, H., & Arsene, C. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae280 · Cited by 84 · see citing works
High lipoprotein(a): Actionable strategies for risk assessment and mitigation
Reyes‐Soffer, G., Yeang, C., Michos, E. D., Boatwright, W., & Ballantyne, C. M. (2024) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2024.100651 · Cited by 83 · see citing works
Thurston, R. C., Chang, Y., Kline, C. E., Swanson, L. M., Khoudary, S. R. E., Jackson, E. A., & Derby, C. A. (2024) · Circulation · doi:10.1161/circulationaha.123.066491 · Cited by 80 · see citing works
Life’s Essential 8 and Mortality in US Adults with Chronic Kidney Disease
Chen, H., Tang, H., Huang, J., Luo, N., Zhang, X., & Wang, X. (2023) · American Journal of Nephrology · doi:10.1159/000533257 · Cited by 79 · see citing works
Chronotype, Unhealthy Lifestyle, and Diabetes Risk in Middle-Aged U.S. Women
Kianersi, S., Liu, Y., Guasch‐Ferré, M., Redline, S. S., Schernhammer, E. S., Sun, Q., & Huang, T. (2023) · Annals of Internal Medicine · doi:10.7326/m23-0728 · Cited by 77 · see citing works
Ge, J., Peng, W., & Lu, J. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.036669 · Cited by 77 · see citing works
Childhood Non-HDL Cholesterol and LDL Cholesterol and Adult Atherosclerotic Cardiovascular Events
Wu, F., Juonala, M., Jacobs, D. R., Daniels, S. R., Kähönen, M. A. P., Woo, J. G., Sinaiko, A. R., Viikari, J. S. A., Bazzano, L., Burns, T. L., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.064296 · Cited by 76 · see citing works
Cardiovascular Health Among Rural and Urban US Adults—Healthcare, Lifestyle, and Social Factors
Liu, M., Marinacci, L., Maddox, K. E. J., & Wadhera, R. K. (2025) · JAMA Cardiology · doi:10.1001/jamacardio.2025.0538 · Cited by 76 · see citing works
Khan, S. S., Breathett, K., Braun, L. T., Chow, S. L., Gupta, D. K., Lekavich, C., Lloyd-Jones, D. M., Ndumele, C. E., Rodriguez, C. J., Allen, L. A., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001307 · Cited by 75 · see citing works
Self-citationMutruc, V., Bologa, C., Șorodoc, V., Ceasovschih, A., Morărașu, B. C., Șorodoc, L., Catar, O., & Lionte, C. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14082833 · Cited by 75 · see citing works
Agarwala, A., Patel, J., Stephens, J. D., Roberson, S. L., Scott, J., Beckie, T. M., & Jackson, E. A. (2023) · Circulation · doi:10.1161/cir.0000000000001171 · Cited by 74 · see citing works
Zaleski, A. L., Berkowsky, R. S., Craig, K. J. T., & Pescatello, L. S. (2024) · JMIR Medical Education · doi:10.2196/51308 · Cited by 74 · see citing works
Pregnancy as an Early Cardiovascular Moment: Peripartum Cardiovascular Health
Khan, S. S., Cameron, N. A., & Lindley, K. J. (2023) · Circulation Research · doi:10.1161/circresaha.123.322001 · Cited by 73 · see citing works
Cardiovascular-kidney-metabolic syndrome: A step toward multidisciplinary and inclusive care
Claudel, S. E., & Verma, A. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.10.015 · Cited by 73 · see citing works
Associations Between Life's Essential 8 and Chronic Kidney Disease
Ren, Y.-Q., Cai, Z.-A., Guo, C.-G., Zhang, Y.-Y., Xu, H.-X., Liu, L., Wang, L.-B., Ba, Y., Liu, S.-T., Zhang, G.-J., et al. (2023) · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · doi:10.1161/jaha.123.030564 · Cited by 61 · see citing works
Life's Essential 8 and 10-Year and Lifetime Risk of Atherosclerotic Cardiovascular Disease in China
Jin, C., Li, J., Liu, F., Li, X., Hui, Y., Chen, S., Li, F., Wang, G., Liang, F., Lu, X., et al. (2023) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2023.01.009 · Cited by 72 · see citing works
Lipid-lowering in diabetes: An update
Chait, A., Eckel, R. H., Vrablı́k, M., & Zambon, A. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117313 · Cited by 71 · see citing works
López‐Bueno, R., Núñez‐Cortés, R., Calatayud, J., Salazar‐Méndez, J., Petermann-Rocha, F. E., López‐Gil, J. F., & Cruz, B. D. P. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad176 · Cited by 70 · see citing works
Zheng, Q., Cao, Z., Teng, J., Lü, Q., Huang, P., & Zhou, J. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02742-4 · Cited by 68 · see citing works
Zhou, R., Chen, H.-W., Li, F., Zhong, Q., Huang, Y., & Wu, X. (2023) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2023.05.023 · Cited by 67 · see citing works
- Authors
- Lloyd-Jones, D. M., Allen, N. B., Anderson, C. A. M., Black, T., Brewer, L. C., Foraker, R. E., Grandner, M. A., Lavretsky, H., Perak, A. M., Sharma, G., Rosamond, W., & on behalf of the American Heart Association
- ORCID
- Venue
- Circulation
- Published
- 2022-08-02
- Volume
- 146
- Issue
- 5
- Pages
- e18-e43
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- PMC
- PMC10503546
- OpenAlex
- W4283695295
- Semantic Scholar
- 066c19a643fada4d5e4a9c9a68ac02fb8ca11d10
- Cited by
- 2,785
- References
- 226
- Citations by year
- 2026: 650 · 2025: 916 · 2024: 731 · 2023: 432 · 2022: 54 · 2014: 1
- FWCI
- 108.46
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- American Heart Association
- Centers for Disease Control and Prevention
- National Heart, Lung, and Blood Institute (K23HL145101)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK092950)
- National Institute for Occupational Safety and Health
- National Institute on Minority Health and Health Disparities (R21MD013490, L60 MD012087)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- cardiovascular health, Life's Essential 8, Life's Simple 7, cardiovascular health score, cardiovascular health assessment, diet, physical activity, nicotine exposure, sleep health, body mass index, serum lipids, blood glucose, blood pressure, social determinants of health, mental health, life course, interindividual variability, long-term monitoring
- MeSH terms
- American Heart Association, Blood Pressure, Cardiovascular Diseases, Heart, Humans, Risk Factors, United States, Exercise
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
